Header Logo

Ian

Address
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Pisa P, Kinge CW, Chasela C, Mothibi E, Thaung YM, Thwin HT, Aung NM, Chew KW, Gandhi MM, Clint C, Minior T, Lwin AA, Freiman MJ, Kyi KP, Sein YY, Marange F, van der Horst C, Mohamed S, Barralon M, Sanne I. Evaluation of GeneXpert and advanced biological laboratories UltraGene HCV diagnostic detection and performance against Roche real time PCR in Myanmar. J Clin Virol. 2024 04; 171:105653. PMID: 38408420; PMCID: PMC11178258.
      Citations:    Fields:    Translation:HumansCells
    2. Jassat W, Mudara C, Ozougwu L, Welch R, Arendse T, Masha M, Blumberg L, Kufa T, Puren A, Groome M, Govender N, Pisa P, Govender S, Sanne I, Brahmbhatt H, Parmley L, Wolmarans M, Rousseau P, Selikow A, Burgess M, Hankel L, Parker A, Cohen C. Trends in COVID-19 admissions and deaths among people living with HIV in South Africa: analysis of national surveillance data. Lancet HIV. 2024 Feb; 11(2):e96-e105. PMID: 38296365.
      Citations: 1     Fields:    Translation:HumansCells
    3. Takalani A, Robinson M, Jonas P, Bodenstein A, Sambo V, Jacobson B, Louw V, Opie J, Peter J, Rowji P, Seocharan I, Reddy T, Yende-Zuma N, Khutho K, Sanne I, Bekker LG, Gray G, Garrett N, Goga A, Sisonke Study Team. Safety of a second homologous Ad26.COV2.S vaccine among healthcare workers in the phase 3b implementation Sisonke study in South Africa. Vaccine. 2024 Feb 27; 42(6):1195-1199. PMID: 38278629.
      Citations:    Fields:    Translation:HumansCTClinical Trials
    4. Jassat W, Abdool Karim SS, Ozougwu L, Welch R, Mudara C, Masha M, Rousseau P, Wolmarans M, Selikow A, Govender N, Walaza S, von Gottberg A, Wolter N, Terrence Pisa P, Sanne I, Govender S, Blumberg L, Cohen C, Groome MJ, DATCOV Author Group. Trends in Cases, Hospitalizations, and Mortality Related to the Omicron BA.4/BA.5 Subvariants in South Africa. Clin Infect Dis. 2023 04 17; 76(8):1468-1475. PMID: 36453094; PMCID: PMC10110264.
      Citations: 17     Fields:    Translation:HumansCells
    5. Jacobson BF, Schapkaitz E, Takalani A, Rowji PF, Louw V, Opie J, Bekker LG, Garrett N, Goga A, Reddy T, Zuma NY, Sanne I, Seocharan I, Peter J, Robinson M, Collie S, Khan A, Takuva S, Gray G. Vascular thrombosis after single dose Ad26.COV2.S vaccine in healthcare workers in South Africa: open label, single arm, phase 3B study (Sisonke study). BMJ Med. 2023; 2(1):e000302. PMID: 37063238; PMCID: PMC10083528.
      Citations: 1     
    6. Pettit AC, Phillips PPJ, Kurbatova E, Vernon A, Nahid P, Dawson R, Dooley KE, Sanne I, Waja Z, Mohapi L, Podany AT, Samaneka W, Savic RM, Johnson JL, Muzanyi G, Lalloo UG, Bryant K, Sizemore E, Scott N, Dorman SE, Chaisson RE, Swindells S, Tuberculosis Trials Consortium (TBTC) Study 31/AIDS Clinical Trials Group (ACTG) A5349 study team. Rifapentine With and Without Moxifloxacin for Pulmonary Tuberculosis in People With Human Immunodeficiency Virus (S31/A5349). Clin Infect Dis. 2023 02 08; 76(3):e580-e589. PMID: 36041016; PMCID: PMC10169427.
      Citations: 1     Fields:    Translation:HumansCellsCTClinical Trials
    7. Mekota AM, Gillespie SH, Hoelscher M, Diacon AH, Dawson R, Churchyard G, Sanne I, Minja L, Kibiki G, Maboko L, Lakhi S, Joloba M, Alabi A, Kirenga B, McHugh TD, Grobusch MP, Boeree MJ, PanACEA consortium. Building sustainable clinical trial sites in Sub-Saharan Africa through networking, infrastructure improvement, training and conducting clinical studies: The PanACEA approach. Acta Trop. 2023 Feb; 238:106776. PMID: 36502888.
      Citations: 3     Fields:    Translation:HumansPHPublic Health
    8. Antoniak S, Chasela CS, Freiman MJ, Stopolianska Y, Barnard T, Gandhi MM, Liulchuk M, Tsenilova Z, Viktor T, Dible J, Wose Kinge C, Akpan F, Minior T, Sigwebela N, Mohamed S, Barralon M, Marange F, Cavenaugh C, Horst CV, Antonyak S, Xulu T, Chew KW, Sanne I, Rosen S, for EQUIP Health. Treatment outcomes and costs of a simplified antiretroviral treatment strategy for hepatitis C among Hepatitis C Virus and Human Immuno deficiency Virus co-infected patients in Ukraine. JGH Open. 2022 Dec; 6(12):894-903. PMID: 36514496; PMCID: PMC9730727.
      Citations:    
    9. Moyo K, Igaba N, Wose Kinge C, Chasela C, Phohole M, Grove S, Makura C, Mudau L, Taljaard D, Rech D, Ramkissoon A, Searle C, Majuba P, Sanne I. Voluntary medical male circumcision in selected provinces in South Africa: Outcomes from a programmatic setting. PLoS One. 2022; 17(9):e0270545. PMID: 36149904; PMCID: PMC9506619.
      Citations: 1     Fields:    Translation:Humans
    10. Benade M, Rosen S, Antoniak S, Chasela C, Stopolianska Y, Barnard T, Gandhi MM, Ivanchuk I, Tretiakov V, Dible J, Minior T, Chew KW, van der Horst C, Tsenilova Z, Sanne I. Impact of direct-acting antiviral treatment of hepatitis C on the quality of life of adults in Ukraine. BMC Infect Dis. 2022 Jul 27; 22(1):650. PMID: 35896987; PMCID: PMC9330669.
      Citations:    Fields:    Translation:HumansCells
    11. Maskew M, Sharpey-Schafer K, De Voux L, Crompton T, Bor J, Rennick M, Chirowodza A, Miot J, Molefi S, Onaga C, Majuba P, Sanne I, Pisa P. Applying machine learning and predictive modeling to retention and viral suppression in South African HIV treatment cohorts. Sci Rep. 2022 07 26; 12(1):12715. PMID: 35882962; PMCID: PMC9325703.
      Citations: 8     Fields:    Translation:Humans
    12. Takuva S, Takalani A, Seocharan I, Yende-Zuma N, Reddy T, Engelbrecht I, Faesen M, Khuto K, Whyte C, Bailey V, Trivella V, Peter J, Opie J, Louw V, Rowji P, Jacobson B, Groenewald P, Dorrington RE, Laubscher R, Bradshaw D, Moultrie H, Fairall L, Sanne I, Gail-Bekker L, Gray G, Goga A, Garrett N, Sisonke study team. Safety evaluation of the single-dose Ad26.COV2.S vaccine among healthcare workers in the Sisonke study in South Africa: A phase 3b implementation trial. PLoS Med. 2022 06; 19(6):e1004024. PMID: 35727802; PMCID: PMC9212139.
      Citations: 8     Fields:    Translation:HumansCTClinical Trials
    13. Wose Kinge C, Hanekom S, Lupton-Smith A, Akpan F, Mothibi E, Maotoe T, Lebatie F, Majuba P, Sanne I, Chasela C. Persistent Symptoms among Frontline Health Workers Post-Acute COVID-19 Infection. Int J Environ Res Public Health. 2022 May 13; 19(10). PMID: 35627472.
      Citations: 6     Fields:    Translation:Humans
    14. Morgan JR, Marsh E, Savinkina A, Shilton S, Shadaker S, Tsertsvadze T, Kamkamidze G, Alkhazashvili M, Morgan T, Belperio P, Backus L, Doss W, Esmat G, Hassany M, Elsharkawy A, Elakel W, Mehrez M, Foster GR, Wose Kinge C, Chew KW, Chasela CS, Sanne IM, Thanung YM, Loarec A, Aslam K, Balkan S, Easterbrook PJ, Linas BP. Determining the lower limit of detection required for HCV viral load assay for test of cure following direct-acting antiviral-based treatment regimens: Evidence from a global data set. J Viral Hepat. 2022 06; 29(6):474-486. PMID: 35278339.
      Citations: 1     Fields:    Translation:HumansCells
    15. Bekker LG, Garrett N, Goga A, Fairall L, Reddy T, Yende-Zuma N, Kassanjee R, Collie S, Sanne I, Boulle A, Seocharan I, Engelbrecht I, Davies MA, Champion J, Chen T, Bennett S, Mametja S, Semenya M, Moultrie H, de Oliveira T, Lessells RJ, Cohen C, Jassat W, Groome M, Von Gottberg A, Le Roux E, Khuto K, Barouch D, Mahomed H, Wolmarans M, Rousseau P, Bradshaw D, Mulder M, Opie J, Louw V, Jacobson B, Rowji P, Peter JG, Takalani A, Odhiambo J, Mayat F, Takuva S, Corey L, Gray GE, Sisonke Protocol Team, Sisonke Study Team. Effectiveness of the Ad26.COV2.S vaccine in health-care workers in South Africa (the Sisonke study): results from a single-arm, open-label, phase 3B, implementation study. Lancet. 2022 03 19; 399(10330):1141-1153. PMID: 35305740; PMCID: PMC8930006.
      Citations: 39     Fields:    Translation:HumansCells
    16. Jugwanth S, Gededzha MP, Mampeule N, Zwane N, David A, Burgers WA, Blackburn JM, Grove JS, George JA, Sanne I, Scott L, Stevens W, Mayne ES. Performance of the Abbott SARS-CoV-2 IgG serological assay in South African 2 patients. PLoS One. 2022; 17(2):e0262442. PMID: 35120133; PMCID: PMC8815965.
      Citations: 7     Fields:    Translation:HumansCells
    17. Henderson M, Fidler S, Mothe B, Grinsztejn B, Haire B, Collins S, Lau JSY, Luba M, Sanne I, Tatoud R, Deeks S, Lewin SR. Mitigation strategies to safely conduct HIV treatment research in the context of COVID-19. J Int AIDS Soc. 2022 02; 25(2):e25882. PMID: 35138683; PMCID: PMC8826545.
      Citations: 1     Fields:    Translation:HumansCellsPHPublic Health
    18. Ovens W, Tomescu S, Harrison E, Crampton T, De Nooy A, Jassat W, Banoo S, Pisa P, Sanne I. Guiding equitable prioritisation of COVID-19 vaccine distribution and strategic deployment in South Africa to enhance effectiveness and access to vulnerable communities and prevent waste. S Afr Med J. 2022 02 01; 112(2):13501. PMID: 35139989.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    19. Goga AE, Bekker LG, Garrett N, Takuva S, Sanne I, Odhiambo J, Mayat F, Fairall L, Brey Z, Bamford L, Tanna G, Grey G. Sisonke phase 3B open-label study: Lessons learnt for national and global vaccination scale-up during epidemics. S Afr Med J. 2021 12 24; 112(2b):13486. PMID: 35140006.
      Citations: 4     Fields:    Translation:HumansCellsPHPublic HealthCTClinical Trials
    20. Peter J, Day C, Takuva S, Takalani A, Engelbrecht I, Garrett N, Goga A, Louw V, Opie J, Jacobson B, Sanne I, Gail-Bekker L, Gray G. Allergic reactions to the Ad26.COV2.S vaccine in South Africa. J Allergy Clin Immunol Glob. 2022 Feb; 1(1):2-8. PMID: 37780073; PMCID: PMC10509997.
      Citations: 1     
    21. David A, Scott L, Jugwanth S, Gededzha M, Kahamba T, Zwane N, Mampeule N, Sanne I, Stevens W, Mayne ES. Operational characteristics of 30 lateral flow immunoassays used to identify COVID-19 immune response. J Immunol Methods. 2021 09; 496:113096. PMID: 34242653; PMCID: PMC8259047.
      Citations: 9     Fields:    Translation:HumansCells
    22. Gededzha MP, Mampeule N, Jugwanth S, Zwane N, David A, Burgers WA, Blackburn JM, Grove JS, George JA, Sanne I, Scott L, Stevens W, Mayne ES. Performance of the EUROIMMUN Anti-SARS-CoV-2 ELISA Assay for detection of IgA and IgG antibodies in South Africa. PLoS One. 2021; 16(6):e0252317. PMID: 34161348; PMCID: PMC8221517.
      Citations: 13     Fields:    Translation:Humans
    23. Takuva S, Takalani A, Garrett N, Goga A, Peter J, Louw V, Opie J, Jacobson B, Sanne I, Gail-Bekker L, Gray G. Thromboembolic Events in the South African Ad26.COV2.S Vaccine Study. N Engl J Med. 2021 08 05; 385(6):570-571. PMID: 34077639; PMCID: PMC8190951.
      Citations: 21     Fields:    Translation:Humans
    24. Dorman SE, Nahid P, Kurbatova EV, Phillips PPJ, Bryant K, Dooley KE, Engle M, Goldberg SV, Phan HTT, Hakim J, Johnson JL, Lourens M, Martinson NA, Muzanyi G, Narunsky K, Nerette S, Nguyen NV, Pham TH, Pierre S, Purfield AE, Samaneka W, Savic RM, Sanne I, Scott NA, Shenje J, Sizemore E, Vernon A, Waja Z, Weiner M, Swindells S, Chaisson RE, AIDS Clinical Trials Group, Tuberculosis Trials Consortium. Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis. N Engl J Med. 2021 05 06; 384(18):1705-1718. PMID: 33951360; PMCID: PMC8282329.
      Citations: 167     Fields:    Translation:HumansCellsCTClinical Trials
    25. Nichols BE, Jamieson L, Zhang SRC, Rao GA, Silal S, Pulliam JRC, Sanne I, Meyer-Rath G. The Role of Remdesivir in South Africa: Preventing COVID-19 Deaths Through Increasing Intensive Care Unit Capacity. Clin Infect Dis. 2021 05 04; 72(9):1642-1644. PMID: 32628744; PMCID: PMC7454458.
      Citations: 9     Fields:    Translation:HumansCells
    26. Hoffman RM, Moyo C, Balakasi KT, Siwale Z, Hubbard J, Bardon A, Fox MP, Kakwesa G, Kalua T, Nyasa-Haambokoma M, Dovel K, Campbell PM, Tseng CH, Pisa PT, Cele R, Gupta S, Benade M, Long L, Xulu T, Sanne I, Rosen S. Multimonth dispensing of up to 6 months of antiretroviral therapy in Malawi and Zambia (INTERVAL): a cluster-randomised, non-blinded, non-inferiority trial. Lancet Glob Health. 2021 05; 9(5):e628-e638. PMID: 33865471.
      Citations: 32     Fields:    Translation:Humans
    27. Makatsa MS, Tincho MB, Wendoh JM, Ismail SD, Nesamari R, Pera F, de Beer S, David A, Jugwanth S, Gededzha MP, Mampeule N, Sanne I, Stevens W, Scott L, Blackburn J, Mayne ES, Keeton RS, Burgers WA. SARS-CoV-2 Antigens Expressed in Plants Detect Antibody Responses in COVID-19 Patients. Front Plant Sci. 2021; 12:589940. PMID: 33868324; PMCID: PMC8044419.
      Citations: 25     
    28. Jo Y, Jamieson L, Edoka I, Long L, Silal S, Pulliam JRC, Moultrie H, Sanne I, Meyer-Rath G, Nichols BE. Cost-effectiveness of Remdesivir and Dexamethasone for COVID-19 Treatment in South Africa. Open Forum Infect Dis. 2021 Mar; 8(3):ofab040. PMID: 33732750; PMCID: PMC7928624.
      Citations: 26     
    29. Evans D, van Rensburg C, Govathson C, Ivanova O, Rieß F, Siroka A, Sillah AK, Ntinginya NE, Jani I, Sathar F, Rosen S, Sanne I, Rachow A, Lönnroth K. Adaptation of WHO's generic tuberculosis patient cost instrument for a longitudinal study in Africa. Glob Health Action. 2021 01 01; 14(1):1865625. PMID: 33491593; PMCID: PMC7850383.
      Citations: 6     Fields:    Translation:Humans
    30. Gray G, Van der Heever A, Madhi SS, McIntyre J, Kana B, Stevens W, Sanne I, Richards G, Abdullah F, Mendelson M, Dasoo A, Nel J, Wulfsohn A, Blumberg L, Venter F. The Scientists' Collective 10-point proposal for equitable and timeous access to COVID-19 vaccine in South Africa. S Afr Med J. 2020 12 14; 0(0):13163. PMID: 33334389.
      Citations:    Fields:    Translation:HumansCellsPHPublic Health
    31. Gray G, Van der Heever A, Madhi S, McIntyre J, Kana B, Stevens W, Sanne I, Richards G, Abdullah F, Mendelson M, Dasoo A, Nel J, Wulfsohn A, Blumberg L, Venter F. The Scientists' Collective 10-point proposal for equitable and timeous access to COVID-19 vaccine in South Africa. S Afr Med J. 2020 12 14; 111(2):89-94. PMID: 33944712.
      Citations: 2     Fields:    Translation:HumansCellsPHPublic Health
    32. Parker VR, Bennet JA, Sanne IM. An incidental finding of chronic lymphocytic leukaemia in a patient with pulmonary tuberculosis. S Afr J Infect Dis. 2020; 35(1):218. PMID: 34485482; PMCID: PMC8378191.
      Citations: 1     
    33. Tukei BB, Fatti G, Tiam A, Ngorima-Mabhena N, Tukei VJ, Tshabalala I, Sejana VM, Muzenda T, Mokoroane LM, Sehlabo L, Maotoe T, Mirembe JK, Membe I, Akpan F, Maile K, Faturiyele I, Xulu T, Minior T, Sanne I, Chasela C, for EQUIP Health. Twelve-Month Outcomes of Community-Based Differentiated Models of Multimonth Dispensing of ART Among Stable HIV-Infected Adults in Lesotho: A Cluster-Randomized Noninferiority Trial. J Acquir Immune Defic Syndr. 2020 11 01; 85(3):280-291. PMID: 32665460.
      Citations: 26     Fields:    Translation:Humans
    34. Min Thaung Y, Chasela CS, Chew KW, Minior T, Lwin AA, Sein YY, Drame N, Marange F, van der Horst C, Thwin HT, Freiman MJ, Gandhi MM, Bijl M, Wose Kinge C, Rosen S, Thura S, Mohamed S, Xulu T, Naing AY, Barralon M, Cavenaugh C, Kyi KP, Sanne I, for EQUIP Health. Treatment outcomes and costs of a simplified antiviral treatment strategy for hepatitis C among monoinfected and HIV and/or hepatitis B virus-co-infected patients in Myanmar. J Viral Hepat. 2021 01; 28(1):147-158. PMID: 32935438; PMCID: PMC7746582.
      Citations: 12     Fields:    Translation:HumansCells
    35. Jo Y, Jamieson L, Edoka I, Long L, Silal S, Pulliam JRC, Moultrie H, Sanne I, Meyer-Rath G, Nichols BE. Cost-effectiveness of remdesivir and dexamethasone for COVID-19 treatment in South Africa. medRxiv. 2020 Sep 27. PMID: 32995824; PMCID: PMC7523165.
      Citations: 1     
    36. Mayne ES, Scott L, Semete B, Julsing A, Jugwanth S, Mampeule N, David A, Gededzha MP, Goga A, Hardie D, Preiser W, Chetty K, Rees H, Sanne I, Mlisana K, George JA, Stevens W. The role of serological testing in the SARS-CoV-2 outbreak. S Afr Med J. 2020 07 17; 110(9):842-845. PMID: 32880264.
      Citations: 6     Fields:    Translation:HumansCellsPHPublic Health
    37. Noble L, Scott L, Stewart-Isherwood L, Molifi SJ, Sanne I, Da Silva P, Stevens W. Continuous quality monitoring in the field: an evaluation of the performance of the Fio Deki Reader™ for rapid HIV testing in South Africa. BMC Infect Dis. 2020 May 04; 20(1):320. PMID: 32366227; PMCID: PMC7199324.
      Citations: 4     Fields:    Translation:HumansCellsPHPublic Health
    38. Giron LB, Papasavvas E, Azzoni L, Yin X, Anzurez A, Damra M, Mounzer K, Kostman JR, Sanne I, Firnhaber CS, Tateno H, Liu Q, Montaner LJ, Abdel-Mohsen M. Plasma and antibody glycomic biomarkers of time to HIV rebound and viral setpoint. AIDS. 2020 04 01; 34(5):681-686. PMID: 31972605; PMCID: PMC7072000.
      Citations: 13     Fields:    Translation:HumansCells
    39. Hoffman RM, Balakasi K, Bardon AR, Siwale Z, Hubbard J, Kakwesa G, Haambokoma M, Kalua T, Pisa P, Moyo C, Dovel K, Xulu T, Sanne I, Fox M, Rosen S. Eligibility for differentiated models of HIV treatment service delivery: an estimate from Malawi and Zambia. AIDS. 2020 03 01; 34(3):475-479. PMID: 31764076.
      Citations: 8     Fields:    Translation:Humans
    40. Brennan AT, Berry KM, Rosen S, Stokes A, Crowther NJ, George J, Raal F, Cassim N, Sanne I, Long L, Fox MP. Growth curve modelling to determine distinct BMI trajectory groups in HIV-positive adults on antiretroviral therapy in South Africa. AIDS. 2019 11 01; 33(13):2049-2059. PMID: 31577571; PMCID: PMC6939155.
      Citations: 7     Fields:    Translation:Humans
    41. Hendrickson C, Evans D, Brennan AT, Patz S, Untiedt S, Bassett J, Levin L, Sanne I, Fox MP. Treatment outcomes among HIV-positive orphaned and non-orphaned children on antiretroviral therapy in Johannesburg, South Africa. S Afr Med J. 2019 Aug 28; 109(9):679-685. PMID: 31635594.
      Citations: 3     Fields:    Translation:Humans
    42. Schwartz SR, Bassett J, Mutunga L, Yende N, Mudavanhu M, Phofa R, Sanne I, Van Rie A. HIV incidence, pregnancy, and implementation outcomes from the Sakh'umndeni safer conception project in South Africa: a prospective cohort study. Lancet HIV. 2019 07; 6(7):e438-e446. PMID: 31160268; PMCID: PMC6660144.
      Citations: 23     Fields:    Translation:Humans
    43. Robertson KR, Oladeji B, Jiang H, Kumwenda J, Supparatpinyo K, Campbell TB, Hakim J, Tripathy S, Hosseinipour MC, Marra CM, Kumarasamy N, Evans S, Vecchio A, La Rosa A, Santos B, Silva MT, Montano S, Kanyama C, Firnhaber C, Price R, Marcus C, Berzins B, Masih R, Lalloo U, Sanne I, Yosief S, Walawander A, Nair A, Sacktor N, Hall C, 5199 Study Team; and the AIDS Clinical Trials Group. Human Immunodeficiency Virus Type 1 and Tuberculosis Coinfection in Multinational, Resource-limited Settings: Increased Neurological Dysfunction. Clin Infect Dis. 2019 05 02; 68(10):1739-1746. PMID: 30137250; PMCID: PMC6495021.
      Citations: 5     Fields:    Translation:HumansCells
    44. Papasavvas E, Kossenkov AV, Azzoni L, Zetola NM, Mackiewicz A, Ross BN, Fair M, Vadrevu S, Ramogola-Masire D, Sanne I, Firnhaber C, Montaner LJ. Gene expression profiling informs HPV cervical histopathology but not recurrence/relapse after LEEP in ART-suppressed HIV+HPV+ women. Carcinogenesis. 2019 04 29; 40(2):225-233. PMID: 30364933; PMCID: PMC6487677.
      Citations: 3     Fields:    Translation:HumansCells
    45. Hendrickson C, Moolla A, Maskew M, Long L, Fox MP, Sanne I, Majuba P, Pascoe S. "Even if you're HIV-positive there's life after if you take your medication": experiences of people on long-term ART in South Africa: a short report. AIDS Care. 2019 08; 31(8):973-978. PMID: 30913899.
      Citations: 4     Fields:    Translation:Humans
    46. Rachow A, Ivanova O, Wallis R, Charalambous S, Jani I, Bhatt N, Kampmann B, Sutherland J, Ntinginya NE, Evans D, Lönnroth K, Niemann S, Schaible UE, Geldmacher C, Sanne I, Hoelscher M, Churchyard G. TB sequel: incidence, pathogenesis and risk factors of long-term medical and social sequelae of pulmonary TB - a study protocol. BMC Pulm Med. 2019 Jan 07; 19(1):4. PMID: 30616617; PMCID: PMC6323671.
      Citations: 31     Fields:    Translation:HumansCTClinical Trials
    47. Berhanu RH, David A, da Silva P, Shearer K, Sanne I, Stevens W, Scott L. Performance of Xpert MTB/RIF, Xpert Ultra, and Abbott RealTime MTB for Diagnosis of Pulmonary Tuberculosis in a High-HIV-Burden Setting. J Clin Microbiol. 2018 12; 56(12). PMID: 30305387; PMCID: PMC6258835.
      Citations: 26     Fields:    Translation:HumansCells
    48. Hirasen K, Berhanu R, Evans D, Rosen S, Sanne I, Long L. High rates of death and loss to follow-up by 12 months of rifampicin resistant TB treatment in South Africa. PLoS One. 2018; 13(10):e0205463. PMID: 30300403; PMCID: PMC6177165.
      Citations: 5     Fields:    Translation:Humans
    49. Brennan AT, Jamieson L, Crowther NJ, Fox MP, George JA, Berry KM, Stokes A, Maskew M, Sanne I, Long L, Cassim N, Rosen S. Prevalence, incidence, predictors, treatment, and control of hypertension among HIV-positive adults on antiretroviral treatment in public sector treatment programs in South Africa. PLoS One. 2018; 13(10):e0204020. PMID: 30281618; PMCID: PMC6169897.
      Citations: 45     Fields:    Translation:Humans
    50. Long LC, Evans D, Rosen S, Sauls C, Brennan AT, Sanne IM, Fox MP. Can routine inpatient mortality data improve HIV mortality estimates? Inpatient mortality at an urban hospital in South Africa. S Afr Med J. 2018 Oct 02; 108(10):870-875. PMID: 30421717.
      Citations: 5     Fields:    
    51. Maskew M, Jamieson L, Mohomi G, Long L, Mongwenyana C, Nyoni C, Mokaba D, Fox MP, Sanne I, Rosen S. Implementation of Option B and a fixed-dose combination antiretroviral regimen for prevention of mother-to-child transmission of HIV in South Africa: A model of uptake and adherence to care. PLoS One. 2018; 13(8):e0201955. PMID: 30161147; PMCID: PMC6116946.
      Citations: 2     Fields:    Translation:HumansPHPublic Health
    52. Svensson EM, Svensson RJ, Te Brake LHM, Boeree MJ, Heinrich N, Konsten S, Churchyard G, Dawson R, Diacon AH, Kibiki GS, Minja LT, Ntingiya NE, Sanne I, Gillespie SH, Hoelscher M, Phillips PPJ, Simonsson USH, Aarnoutse R. The Potential for Treatment Shortening With Higher Rifampicin Doses: Relating Drug Exposure to Treatment Response in Patients With Pulmonary Tuberculosis. Clin Infect Dis. 2018 06 18; 67(1):34-41. PMID: 29917079; PMCID: PMC6005123.
      Citations: 51     Fields:    Translation:Humans
    53. Bonawitz R, Brennan AT, Long L, Heeren T, Maskew M, Sanne I, Fox MP. Regimen durability in HIV-infected children and adolescents initiating first-line antiretroviral therapy in a large public sector HIV cohort in South Africa. Trop Med Int Health. 2018 06; 23(6):650-660. PMID: 29656449; PMCID: PMC8273497.
      Citations: 2     Fields:    Translation:Humans
    54. Evans D, Hirasen K, Berhanu R, Malete G, Ive P, Spencer D, Badal-Faesen S, Sanne IM, Fox MP. Predictors of switch to and early outcomes on third-line antiretroviral therapy at a large public-sector clinic in Johannesburg, South Africa. AIDS Res Ther. 2018 04 10; 15(1):10. PMID: 29636106; PMCID: PMC5891887.
      Citations: 11     Fields:    Translation:HumansPHPublic Health
    55. Hirasen K, Evans D, Maskew M, Sanne IM, Shearer K, Govathson C, Malete G, Kluberg SA, Fox MP. The right combination - treatment outcomes among HIV-positive patients initiating first-line fixed-dose antiretroviral therapy in a public sector HIV clinic in Johannesburg, South Africa. Clin Epidemiol. 2018; 10:17-29. PMID: 29296098; PMCID: PMC5739109.
      Citations: 12     
    56. Meyer-Rath G, Johnson LF, Pillay Y, Blecher M, Brennan AT, Long L, Moultrie H, Sanne I, Fox MP, Rosen S. Changing the South African national antiretroviral therapy guidelines: The role of cost modelling. PLoS One. 2017; 12(10):e0186557. PMID: 29084275; PMCID: PMC5662079.
      Citations: 31     Fields:    Translation:Humans
    57. Hoffman R, Bardon A, Rosen S, Fox M, Kalua T, Xulu T, Taylor A, Sanne I. Varying intervals of antiretroviral medication dispensing to improve outcomes for HIV patients (The INTERVAL Study): study protocol for a randomized controlled trial. Trials. 2017 Oct 13; 18(1):476. PMID: 29029644; PMCID: PMC5640907.
      Citations: 10     Fields:    Translation:Humans
    58. Nel JS, Lippincott CK, Berhanu R, Spencer DC, Sanne IM, Ive P. Does Disseminated Nontuberculous Mycobacterial Disease Cause False-Positive Determine TB-LAM Lateral Flow Assay Results? A Retrospective Review. Clin Infect Dis. 2017 10 01; 65(7):1226-1228. PMID: 28575238.
      Citations: 9     Fields:    Translation:HumansCells
    59. Stevens WS, Gous NM, MacLeod WB, Long LC, Variava E, Martinson NA, Sanne I, Osih R, Scott LE. Multidisciplinary Point-of-Care Testing in South African Primary Health Care Clinics Accelerates HIV ART Initiation but Does Not Alter Retention in Care. J Acquir Immune Defic Syndr. 2017 09 01; 76(1):65-73. PMID: 28542080.
      Citations: 18     Fields:    Translation:HumansPHPublic Health
    60. Badal-Faesen S, Firnhaber C, Kendall MA, Wu X, Grinsztejn B, Escada RODS, Fernandez M, Hogg E, Sanne I, Johnson P, Alland D, Mazurek GH, Benator DA, Luetkemeyer AF, AIDS Clinical Trials Group A5295, Tuberculosis Trials Consortium Study 34 Teams. Impact of Larger Sputum Volume on Xpert® MTB/RIF Assay Detection of Mycobacterium tuberculosis in Smear-Negative Individuals with Suspected Tuberculosis. J Clin Med. 2017 Aug 07; 6(8). PMID: 28783093; PMCID: PMC5575580.
      Citations: 4     
    61. Long LC, Maskew M, Brennan AT, Mongwenyana C, Nyoni C, Malete G, Sanne I, Fox MP, Rosen S. Initiating antiretroviral therapy for HIV at a patient's first clinic visit: a cost-effectiveness analysis of the rapid initiation of treatment randomized controlled trial. AIDS. 2017 Jul 17; 31(11):1611-1619. PMID: 28463879; PMCID: PMC5512863.
      Citations: 14     Fields:    Translation:Humans
    62. Fox MP, Maskew M, Brennan AT, Evans D, Onoya D, Malete G, MacPhail P, Bassett J, Ebrahim O, Mabotja D, Mashamaite S, Long L, Sanne I. Cohort profile: the Right to Care Clinical HIV Cohort, South Africa. BMJ Open. 2017 06 10; 7(6):e015620. PMID: 28601835; PMCID: PMC5724130.
      Citations: 12     Fields:    Translation:Humans
    63. Belaunzarán-Zamudio PF, Azzoni L, Canaday DH, Caro-Vega YN, Clagett B, Rassool MS, Rodriguez B, Sanne I, Sereti I, Sierra-Madero JG, Lederman MM. Immunologic Effects of Maraviroc in HIV-Infected Patients with Severe CD4 Lymphopenia Starting Antiretroviral Therapy: A Sub-Study of the CADIRIS Trial. Pathog Immun. 2017; 2(2):151-177. PMID: 28736763; PMCID: PMC5518704.
      Citations: 3     
    64. Schwartz SR, Bassett J, Holmes CB, Yende N, Phofa R, Sanne I, Van Rie A. Client uptake of safer conception strategies: implementation outcomes from the Sakh'umndeni Safer Conception Clinic in South Africa. J Int AIDS Soc. 2017 03 08; 20(Suppl 1):21291. PMID: 28361507; PMCID: PMC5577727.
      Citations: 22     Fields:    Translation:HumansPHPublic Health
    65. Shearer K, Clouse K, Meyer-Rath G, MacLeod W, Maskew M, Sanne I, Long L, Fox MP. Citizenship status and engagement in HIV care: an observational cohort study to assess the association between reporting a national ID number and retention in public-sector HIV care in Johannesburg, South Africa. BMJ Open. 2017 01 24; 7(1):e013908. PMID: 28119389; PMCID: PMC5278236.
      Citations: 4     Fields:    Translation:Humans
    66. Lippman SA, Pettifor A, Rebombo D, Julien A, Wagner RG, Kang Dufour MS, Kabudula CW, Neilands TB, Twine R, Gottert A, Gómez-Olivé FX, Tollman SM, Sanne I, Peacock D, Kahn K. Evaluation of the Tsima community mobilization intervention to improve engagement in HIV testing and care in South Africa: study protocol for a cluster randomized trial. Implement Sci. 2017 Jan 17; 12(1):9. PMID: 28095904; PMCID: PMC5240325.
      Citations: 17     Fields:    Translation:Humans
    67. Maskew M, Bor J, Hendrickson C, MacLeod W, Bärnighausen T, Pillay D, Sanne I, Carmona S, Stevens W, Fox MP. Imputing HIV treatment start dates from routine laboratory data in South Africa: a validation study. BMC Health Serv Res. 2017 Jan 17; 17(1):41. PMID: 28095905; PMCID: PMC5240407.
      Citations: 16     Fields:    Translation:Humans
    68. Manion M, Andrade BB, DerSimonian R, Gu W, Rupert A, Musselwhite LW, Sierra-Madero JG, Belaunzaran-Zamudio PF, Sanne I, Lederman MM, Sereti I. Country of residence is associated with distinct inflammatory biomarker signatures in HIV-infected patients. J Virus Erad. 2017 Jan 01; 3(1):24-33. PMID: 28275455; PMCID: PMC5337418.
      Citations: 8     
    69. Brennan AT, Bor J, Davies MA, Conradie F, Maskew M, Long L, Sanne I, Fox MP. Tenofovir stock shortages have limited impact on clinic- and patient-level HIV treatment outcomes in public sector clinics in South Africa. Trop Med Int Health. 2017 02; 22(2):241-251. PMID: 27862762.
      Citations: 8     Fields:    Translation:Humans
    70. Long LC, Rosen SB, Brennan A, Moyo F, Sauls C, Evans D, Modi SL, Sanne I, Fox MP. Treatment Outcomes and Costs of Providing Antiretroviral Therapy at a Primary Health Clinic versus a Hospital-Based HIV Clinic in South Africa. PLoS One. 2016; 11(12):e0168118. PMID: 27942005; PMCID: PMC5152901.
      Citations: 9     Fields:    Translation:Humans
    71. Steegen K, Carmona S, Bronze M, Papathanasopoulos MA, van Zyl G, Goedhals D, MacLeod W, Sanne I, Stevens WS. Moderate Levels of Pre-Treatment HIV-1 Antiretroviral Drug Resistance Detected in the First South African National Survey. PLoS One. 2016; 11(12):e0166305. PMID: 27907009; PMCID: PMC5132262.
      Citations: 33     Fields:    Translation:HumansCells
    72. Shearer K, Evans D, Moyo F, Rohr JK, Berhanu R, Van Den Berg L, Long L, Sanne I, Fox MP. Treatment outcomes of over 1000 patients on second-line, protease inhibitor-based antiretroviral therapy from four public-sector HIV treatment facilities across Johannesburg, South Africa. Trop Med Int Health. 2017 02; 22(2):221-231. PMID: 27797443; PMCID: PMC5288291.
      Citations: 9     Fields:    Translation:Humans
    73. Ncayiyana JR, Bassett J, West N, Westreich D, Musenge E, Emch M, Pettifor A, Hanrahan CF, Schwartz SR, Sanne I, van Rie A. Prevalence of latent tuberculosis infection and predictive factors in an urban informal settlement in Johannesburg, South Africa: a cross-sectional study. BMC Infect Dis. 2016 11 08; 16(1):661. PMID: 27825307; PMCID: PMC5101651.
      Citations: 25     Fields:    Translation:HumansCells
    74. Berhanu R, Schnippel K, Mohr E, Hirasen K, Evans D, Rosen S, Sanne I. Early Outcomes Of Decentralized Care for Rifampicin-Resistant Tuberculosis in Johannesburg, South Africa: An Observational Cohort Study. PLoS One. 2016; 11(11):e0164974. PMID: 27812140; PMCID: PMC5094796.
      Citations: 7     Fields:    Translation:Humans
    75. Boeree MJ, Heinrich N, Aarnoutse R, Diacon AH, Dawson R, Rehal S, Kibiki GS, Churchyard G, Sanne I, Ntinginya NE, Minja LT, Hunt RD, Charalambous S, Hanekom M, Semvua HH, Mpagama SG, Manyama C, Mtafya B, Reither K, Wallis RS, Venter A, Narunsky K, Mekota A, Henne S, Colbers A, van Balen GP, Gillespie SH, Phillips PPJ, Hoelscher M, PanACEA consortium. High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial. Lancet Infect Dis. 2017 01; 17(1):39-49. PMID: 28100438; PMCID: PMC5159618.
      Citations: 156     Fields:    Translation:Humans
    76. Steegen K, Bronze M, Papathanasopoulos MA, van Zyl G, Goedhals D, Van Vuuren C, Macleod W, Sanne I, Stevens WS, Carmona SC. Prevalence of Antiretroviral Drug Resistance in Patients Who Are Not Responding to Protease Inhibitor-Based Treatment: Results From the First National Survey in South Africa. J Infect Dis. 2016 Dec 15; 214(12):1826-1830. PMID: 27923946.
      Citations: 14     Fields:    Translation:HumansCells
    77. Rohr JK, Ive P, Horsburgh CR, Berhanu R, Shearer K, Maskew M, Long L, Sanne I, Bassett J, Ebrahim O, Fox MP. Developing a predictive risk model for first-line antiretroviral therapy failure in South Africa. J Int AIDS Soc. 2016; 19(1):20987. PMID: 27677395; PMCID: PMC5039239.
      Citations: 15     Fields:    
    78. Steegen K, Bronze M, Papathanasopoulos MA, van Zyl G, Goedhals D, Variava E, MacLeod W, Sanne I, Stevens WS, Carmona S. HIV-1 antiretroviral drug resistance patterns in patients failing NNRTI-based treatment: results from a national survey in South Africa. J Antimicrob Chemother. 2017 01; 72(1):210-219. PMID: 27659733.
      Citations: 21     Fields:    Translation:HumansCells
    79. Rohr JK, Ive P, Horsburgh CR, Berhanu R, Shearer K, Maskew M, Long L, Sanne I, Bassett J, Ebrahim O, Fox MP. Marginal Structural Models to Assess Delays in Second-Line HIV Treatment Initiation in South Africa. PLoS One. 2016; 11(8):e0161469. PMID: 27548695; PMCID: PMC4993510.
      Citations: 29     Fields:    Translation:HumansCells
    80. Brennan AT, Bonawitz R, Schnippel K, Berhanu R, Maskew M, Long L, Bassett J, Sanne I, Fox MP. Incident tuberculosis in HIV-positive children, adolescents and adults on antiretroviral therapy in South Africa. Int J Tuberc Lung Dis. 2016 08; 20(8):1040-5. PMID: 27393537.
      Citations: 7     Fields:    Translation:Humans
    81. Balagopal A, Gupte N, Shivakoti R, Cox AL, Yang WT, Berendes S, Mwelase N, Kanyama C, Pillay S, Samaneka W, Santos B, Poongulali S, Tripathy S, Riviere C, Lama JR, Cardoso SW, Sugandhavesa P, Semba RD, Hakim J, Hosseinipour MC, Kumarasamy N, Sanne I, Asmuth D, Campbell T, Bollinger RC, Gupta A. Continued Elevation of Interleukin-18 and Interferon-? After Initiation of Antiretroviral Therapy and Clinical Failure in a Diverse Multicountry Human Immunodeficiency Virus Cohort. Open Forum Infect Dis. 2016 Sep; 3(3):ofw118. PMID: 27800521; PMCID: PMC5084713.
      Citations: 11     
    82. Rosen S, Maskew M, Fox MP, Nyoni C, Mongwenyana C, Malete G, Sanne I, Bokaba D, Sauls C, Rohr J, Long L. Correction: Initiating Antiretroviral Therapy for HIV at a Patient's First Clinic Visit: The RapIT Randomized Controlled Trial. PLoS Med. 2016 Jun; 13(6):e1002050. PMID: 27258028; PMCID: PMC4892484.
      Citations: 3     Fields:    
    83. Rosen S, Maskew M, Fox MP, Nyoni C, Mongwenyana C, Malete G, Sanne I, Bokaba D, Sauls C, Rohr J, Long L. Initiating Antiretroviral Therapy for HIV at a Patient's First Clinic Visit: The RapIT Randomized Controlled Trial. PLoS Med. 2016 May; 13(5):e1002015. PMID: 27163694; PMCID: PMC4862681.
      Citations: 171     Fields:    Translation:Humans
    84. Moyo F, Chasela C, Brennan AT, Ebrahim O, Sanne IM, Long L, Evans D. Treatment outcomes of HIV-positive patients on first-line antiretroviral therapy in private versus public HIV clinics in Johannesburg, South Africa. Clin Epidemiol. 2016; 8:37-47. PMID: 27051316; PMCID: PMC4807894.
      Citations: 14     
    85. Long LC, Fox MP, Sauls C, Evans D, Sanne I, Rosen SB. The High Cost of HIV-Positive Inpatient Care at an Urban Hospital in Johannesburg, South Africa. PLoS One. 2016; 11(2):e0148546. PMID: 26885977; PMCID: PMC4757549.
      Citations: 13     Fields:    Translation:Humans
    86. Luetkemeyer AF, Firnhaber C, Kendall MA, Wu X, Mazurek GH, Benator DA, Arduino R, Fernandez M, Guy E, Johnson P, Metchock B, Sattler F, Telzak E, Wang YF, Weiner M, Swindells S, Sanne IM, Havlir DV, Grinsztejn B, Alland D, AIDS Clinical Trials Group A5295 and Tuberculosis Trials Consortium Study 34 Teams. Evaluation of Xpert MTB/RIF Versus AFB Smear and Culture to Identify Pulmonary Tuberculosis in Patients With Suspected Tuberculosis From Low and Higher Prevalence Settings. Clin Infect Dis. 2016 May 01; 62(9):1081-8. PMID: 26839383; PMCID: PMC4826450.
      Citations: 32     Fields:    Translation:HumansCells
    87. Gous NM, Scott LE, Potgieter J, Ntabeni L, Sanne I, Stevens WS. Implementation and Operational Research: Implementation of Multiple Point-of-Care Testing in 2 HIV Antiretroviral Treatment Clinics in South Africa. J Acquir Immune Defic Syndr. 2016 Feb 01; 71(2):e34-43. PMID: 26484742.
      Citations: 13     Fields:    Translation:Humans
    88. Musselwhite LW, Andrade BB, Ellenberg SS, Tierney A, Belaunzaran-Zamudio PF, Rupert A, Lederman MM, Sanne I, Sierra Madero JG, Sereti I. Vitamin D, D-dimer, Interferon ?, and sCD14 Levels are Independently Associated with Immune Reconstitution Inflammatory Syndrome: A Prospective, International Study. EBioMedicine. 2016 Feb; 4:115-23. PMID: 26981576; PMCID: PMC4776072.
      Citations: 26     Fields:    Translation:HumansCells
    89. Robertson K, Jiang H, Evans SR, Marra CM, Berzins B, Hakim J, Sacktor N, Silva MT, Campbell TB, Nair A, Schouten J, 5271 study team, Kumwenda J, Supparatpinyo K, Tripathy S, Kumarasamy N, la Rosa A, Montano S, Mwafongo A, Firnhaber C, Sanne I, Naini L, Amod F, Walawander A, AIDS Clinical Trials Group. International neurocognitive normative study: neurocognitive comparison data in diverse resource-limited settings: AIDS Clinical Trials Group A5271. J Neurovirol. 2016 08; 22(4):472-8. PMID: 26733457; PMCID: PMC4981921.
      Citations: 22     Fields:    Translation:Humans
    90. Jansen van Vuren P, Grobbelaar A, Storm N, Conteh O, Konneh K, Kamara A, Sanne I, Paweska JT. Comparative Evaluation of the Diagnostic Performance of the Prototype Cepheid GeneXpert Ebola Assay. J Clin Microbiol. 2016 Feb; 54(2):359-67. PMID: 26637383; PMCID: PMC4733181.
      Citations: 19     Fields:    Translation:HumansCells
    91. Patro SC, Azzoni L, Joseph J, Fair MG, Sierra-Madero JG, Rassool MS, Sanne I, Montaner LJ. Antiretroviral therapy in HIV-1-infected individuals with CD4 count below 100 cells/mm3 results in differential recovery of monocyte activation. J Leukoc Biol. 2016 07; 100(1):223-31. PMID: 26609048; PMCID: PMC4946615.
      Citations: 7     Fields:    Translation:HumansCells
    92. Budgell EP, Maskew M, Long L, Sanne I, Fox MP. Brief Report: Does Most Mortality in Patients on ART Occur in Care or After Lost to Follow-Up? Evidence From the Themba Lethu Clinic, South Africa. J Acquir Immune Defic Syndr. 2015 Nov 01; 70(3):323-8. PMID: 26181816; PMCID: PMC4627171.
      Citations: 6     Fields:    Translation:Humans
    93. Holmes CB, Sanne I. Changing models of care to improve progression through the HIV treatment cascade in different populations. Curr Opin HIV AIDS. 2015 Nov; 10(6):447-50. PMID: 26352397.
      Citations: 17     Fields:    Translation:Humans
    94. Knight M, van Zyl RL, Sanne I, Bassett J, van Rie A. Impact of combination antiretroviral therapy initiation on adherence to antituberculosis treatment. South Afr J HIV Med. 2015; 16(1):346. PMID: 29568579; PMCID: PMC5850563.
      Citations: 2     
    95. West N, Schwartz S, Phofa R, Yende N, Bassett J, Sanne I, Van Rie A. "I don't know if this is right … but this is what I'm offering": healthcare provider knowledge, practice, and attitudes towards safer conception for HIV-affected couples in the context of Southern African guidelines. AIDS Care. 2016; 28(3):390-6. PMID: 26445035; PMCID: PMC4882088.
      Citations: 21     Fields:    Translation:HumansPHPublic Health
    96. Schwartz SR, West N, Phofa R, Yende N, Sanne I, Bassett J, Van Rie A. Acceptability and preferences for safer conception HIV prevention strategies: a qualitative study. Int J STD AIDS. 2016 10; 27(11):984-92. PMID: 26384950; PMCID: PMC4889551.
      Citations: 24     Fields:    Translation:HumansPHPublic Health
    97. d'Elia A, Evans D, McNamara L, Berhanu R, Sanne I, Lönnermark E. Predictive and prognostic properties of TB-LAM among HIV-positive patients initiating ART in Johannesburg, South Africa. Pan Afr Med J. 2015; 22:4. PMID: 26600904; PMCID: PMC4643149.
      Citations: 5     Fields:    Translation:Humans
    98. Zumla A, Maeurer M, Host-Directed Therapies Network, Chakaya J, Hoelscher M, Ntoumi F, Rustomjee R, Vilaplana C, Yeboah-Manu D, Rasolof V, Munderi P, Singh N, Aklillu E, Padayatchi N, Macete E, Kapata N, Mulenga M, Kibiki G, Mfinanga S, Nyirenda T, Maboko L, Garcia-Basteiro A, Rakotosamimanana N, Bates M, Mwaba P, Reither K, Gagneux S, Edwards S, Mfinanga E, Abdulla S, Cardona PJ, Russell JB, Gant V, Noursadeghi M, Elkington P, Bonnet M, Menendez C, Dieye TN, Diarra B, Maiga A, Aseffa A, Parida S, Wejse C, Petersen E, Kaleebu P, Oliver M, Craig G, Corrah T, Tientcheu L, Antonio M, Rao M, McHugh TD, Sheikh A, Ippolito G, Ramjee G, Kaufmann SH, Churchyard G, Steyn A, Grobusch M, Sanne I, Martinson N, Madansein R, Wilkinson RJ, Mayosi B, Schito M, Wallis RS. Towards host-directed therapies for tuberculosis. Nat Rev Drug Discov. 2015 Aug; 14(8):511-2. PMID: 26184493.
      Citations: 60     Fields:    Translation:HumansCells
    99. Hanrahan CF, Clouse K, Bassett J, Mutunga L, Selibas K, Stevens W, Scott L, Sanne I, Van Rie A. The patient impact of point-of-care vs. laboratory placement of Xpert(®) MTB/RIF. Int J Tuberc Lung Dis. 2015 Jul; 19(7):811-6. PMID: 26056107; PMCID: PMC4869324.
      Citations: 21     Fields:    Translation:HumansCells
    100. Van Den Handel T, Hampton KH, Sanne I, Stevens W, Crous R, Van Rie A. The impact of Xpert(®) MTB/RIF in sparsely populated rural settings. Int J Tuberc Lung Dis. 2015 Apr; 19(4):392-8. PMID: 25859993.
      Citations: 18     Fields:    Translation:Humans
    101. Luetkemeyer AF, Rosenkranz SL, Lu D, Grinsztejn B, Sanchez J, Ssemmanda M, Sanne I, McIlleron H, Havlir DV, Haas DW, Adult AIDS Clinical Trials Group A5221 and A5243 Study Teams. Combined effect of CYP2B6 and NAT2 genotype on plasma efavirenz exposure during rifampin-based antituberculosis therapy in the STRIDE study. Clin Infect Dis. 2015 Jun 15; 60(12):1860-3. PMID: 25722197; PMCID: PMC4542662.
      Citations: 12     Fields:    Translation:Humans
    102. Mahomed S, Behrens K, Slabbert M, Sanne I. Managing Human Tissue Transfer Across National Boundaries - An Approach from an Institution in South Africa. Dev World Bioeth. 2016 Apr; 16(1):29-35. PMID: 25688848.
      Citations: 1     Fields:    Translation:Humans
    103. Van Rie A, Westreich D, Sanne I. Impact of three empirical anti-tuberculosis treatment strategies for people initiating antiretroviral therapy. Int J Tuberc Lung Dis. 2014 Nov; 18(11):1340-6. PMID: 25299868; PMCID: PMC5022588.
      Citations: 2     Fields:    Translation:Humans
    104. Sierra-Madero JG, Ellenberg S, Rassool MS, Tierney A, Belaunzarán-Zamudio PF, López-Martínez A, Piñeirúa-Menéndez A, Montaner LJ, Azzoni L, Benítez CR, Sereti I, Andrade-Villanueva J, Mosqueda-Gómez JL, Rodriguez B, Sanne I, Lederman MM, CADIRIS study team. A Randomized, Double-Blind, Placebo-Controlled Clinical Trial of a Chemokine Receptor 5 (CCR5) Antagonist to Decrease the Occurrence of Immune Reconstitution Inflammatory Syndrome in HIV-Infection: The CADIRIS Study. Lancet HIV. 2014 Nov 01; 1(2):e60-e67. PMID: 26366430; PMCID: PMC4563882.
      Citations: 11     Fields:    
    105. Shearer K, Brennan AT, Maskew M, Long L, Berhanu R, Sanne I, Fox MP. The relation between efavirenz versus nevirapine and virologic failure in Johannesburg, South Africa. J Int AIDS Soc. 2014; 17:19065. PMID: 25361827; PMCID: PMC4215701.
      Citations: 11     Fields:    Translation:HumansCells
    106. Sierra-Madero JG, Ellenberg SS, Rassool MS, Tierney A, Belaunzarán-Zamudio PF, López-Martínez A, Piñeirúa-Menéndez A, Montaner LJ, Azzoni L, Benítez CR, Sereti I, Andrade-Villanueva J, Mosqueda-Gómez JL, Rodriguez B, Sanne I, Lederman MM, CADIRIS study team. Effect of the CCR5 antagonist maraviroc on the occurrence of immune reconstitution inflammatory syndrome in HIV (CADIRIS): a double-blind, randomised, placebo-controlled trial. Lancet HIV. 2014 Nov; 1(2):e60-7. PMID: 26423989.
      Citations: 21     Fields:    
    107. Fox MP, Shearer K, Maskew M, Meyer-Rath G, Clouse K, Sanne I. Attrition through multiple stages of pre-treatment and ART HIV care in South Africa. PLoS One. 2014; 9(10):e110252. PMID: 25330087; PMCID: PMC4203772.
      Citations: 47     Fields:    Translation:Humans
    108. Van Rie A, Clouse K, Hanrahan C, Selibas K, Sanne I, Williams S, Kim P, Bassett J. High uptake of systematic HIV counseling and testing and TB symptom screening at a primary care clinic in South Africa. PLoS One. 2014; 9(9):e105428. PMID: 25268851; PMCID: PMC4182031.
      Citations: 8     Fields:    Translation:HumansPHPublic Health
    109. Clouse K, Hanrahan CF, Bassett J, Fox MP, Sanne I, Van Rie A. Impact of systematic HIV testing on case finding and retention in care at a primary care clinic in South Africa. Trop Med Int Health. 2014 Dec; 19(12):1411-9. PMID: 25244155.
      Citations: 9     Fields:    Translation:HumansPHPublic Health
    110. Evans DH, Fox MP, Maskew M, McNamara L, MacPhail P, Mathews C, Sanne I. CD4 criteria improves the sensitivity of a clinical algorithm developed to identify viral failure in HIV-positive patients on antiretroviral therapy. J Int AIDS Soc. 2014; 17:19139. PMID: 25227265; PMCID: PMC4165719.
      Citations: 7     Fields:    Translation:HumansCells
    111. Schwartz SR, Bassett J, Sanne I, Phofa R, Yende N, Van Rie A. Implementation of a safer conception service for HIV-affected couples in South Africa. AIDS. 2014 Jul; 28 Suppl 3:S277-85. PMID: 24991901; PMCID: PMC4882476.
      Citations: 42     Fields:    Translation:Humans
    112. Hanrahan CF, Theron G, Bassett J, Dheda K, Scott L, Stevens W, Sanne I, Van Rie A. Xpert MTB/RIF as a measure of sputum bacillary burden. Variation by HIV status and immunosuppression. Am J Respir Crit Care Med. 2014 Jun 01; 189(11):1426-34. PMID: 24786895; PMCID: PMC4098085.
      Citations: 34     Fields:    Translation:HumansCells
    113. Deery CB, Hanrahan CF, Selibas K, Bassett J, Sanne I, Van Rie A. A home tracing program for contacts of people with tuberculosis or HIV and patients lost to care. Int J Tuberc Lung Dis. 2014 May; 18(5):534-40. PMID: 24903789; PMCID: PMC4593620.
      Citations: 14     Fields:    Translation:HumansPHPublic Health
    114. Luetkemeyer AF, Kendall MA, Nyirenda M, Wu X, Ive P, Benson CA, Andersen JW, Swindells S, Sanne IM, Havlir DV, Kumwenda J, Adult AIDS Clinical Trials Group A5221 Study Team. Tuberculosis immune reconstitution inflammatory syndrome in A5221 STRIDE: timing, severity, and implications for HIV-TB programs. J Acquir Immune Defic Syndr. 2014 Apr 01; 65(4):423-8. PMID: 24226057; PMCID: PMC3943693.
      Citations: 43     Fields:    Translation:Humans
    115. Shearer K, Maskew M, Ajayi T, Berhanu R, Majuba P, Sanne I, Fox MP. Incidence and predictors of herpes zoster among antiretroviral therapy-naïve patients initiating HIV treatment in Johannesburg, South Africa. Int J Infect Dis. 2014 Jun; 23:56-62. PMID: 24680820; PMCID: PMC4092228.
      Citations: 13     Fields:    Translation:Humans
    116. Grinsztejn B, Hosseinipour MC, Ribaudo HJ, Swindells S, Eron J, Chen YQ, Wang L, Ou SS, Anderson M, McCauley M, Gamble T, Kumarasamy N, Hakim JG, Kumwenda J, Pilotto JH, Godbole SV, Chariyalertsak S, de Melo MG, Mayer KH, Eshleman SH, Piwowar-Manning E, Makhema J, Mills LA, Panchia R, Sanne I, Gallant J, Hoffman I, Taha TE, Nielsen-Saines K, Celentano D, Essex M, Havlir D, Cohen MS, HPTN 052-ACTG Study Team. Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trial. Lancet Infect Dis. 2014 Apr; 14(4):281-90. PMID: 24602844; PMCID: PMC4144040.
      Citations: 272     Fields:    Translation:HumansCellsCTClinical Trials
    117. Brennan AT, Shearer K, Maskew M, Long L, Sanne I, Fox MP. Impact of choice of NRTI in first-line antiretroviral therapy: a cohort analysis of stavudine vs. tenofovir. Trop Med Int Health. 2014 May; 19(5):490-8. PMID: 24589363; PMCID: PMC8224497.
      Citations: 4     Fields:    Translation:Humans
    118. Takuva S, Maskew M, Brennan AT, Long L, Sanne I, Fox MP. Poor CD4 recovery and risk of subsequent progression to AIDS or death despite viral suppression in a South African cohort. J Int AIDS Soc. 2014; 17:18651. PMID: 24594114; PMCID: PMC3942566.
      Citations: 27     Fields:    Translation:Humans
    119. Dawany N, Showe LC, Kossenkov AV, Chang C, Ive P, Conradie F, Stevens W, Sanne I, Azzoni L, Montaner LJ. Identification of a 251 gene expression signature that can accurately detect M. tuberculosis in patients with and without HIV co-infection. PLoS One. 2014; 9(2):e89925. PMID: 24587128; PMCID: PMC3934945.
      Citations: 20     Fields:    Translation:HumansCells
    120. Rosen S, Larson B, Rohr J, Sanne I, Mongwenyana C, Brennan AT, Galárraga O. Effect of antiretroviral therapy on patients' economic well being: five-year follow-up. AIDS. 2014 Jan 28; 28(3):417-24. PMID: 24076660; PMCID: PMC3893293.
      Citations: 10     Fields:    Translation:Humans
    121. Luetkemeyer AF, Kendall MA, Wu X, Lourenço MC, Jentsch U, Swindells S, Qasba SS, Sanchez J, Havlir DV, Grinsztejn B, Sanne IM, Firnhaber C, Adult AIDS Clinical Trials Group A5255 Study Team. Evaluation of two line probe assays for rapid detection of Mycobacterium tuberculosis, tuberculosis (TB) drug resistance, and non-TB Mycobacteria in HIV-infected individuals with suspected TB. J Clin Microbiol. 2014 Apr; 52(4):1052-9. PMID: 24430455; PMCID: PMC3993501.
      Citations: 22     Fields:    Translation:HumansCells
    122. Ndebele P, Blanchard-Horan C, Shahkolahi A, Sanne I. Regulatory challenges associated with conducting multicountry clinical trials in resource-limited settings. J Acquir Immune Defic Syndr. 2014 Jan 01; 65 Suppl 1:S29-31. PMID: 24321981; PMCID: PMC3900239.
      Citations: 10     Fields:    Translation:HumansPHPublic Health
    123. Ive P, MacLeod W, Mkumla N, Orrell C, Jentsch U, Wallis CL, Stevens W, Wood R, Sanne I, Bhattacharya D. Low prevalence of liver disease but regional differences in HBV treatment characteristics mark HIV/HBV co-infection in a South African HIV clinical trial. PLoS One. 2013; 8(12):e74900. PMID: 24324573; PMCID: PMC3855615.
      Citations: 8     Fields:    Translation:HumansCells
    124. Bryant JM, Harris SR, Parkhill J, Dawson R, Diacon AH, van Helden P, Pym A, Mahayiddin AA, Chuchottaworn C, Sanne IM, Louw C, Boeree MJ, Hoelscher M, McHugh TD, Bateson AL, Hunt RD, Mwaigwisya S, Wright L, Gillespie SH, Bentley SD. Whole-genome sequencing to establish relapse or re-infection with Mycobacterium tuberculosis: a retrospective observational study. Lancet Respir Med. 2013 Dec; 1(10):786-92. PMID: 24461758; PMCID: PMC3861685.
      Citations: 93     Fields:    Translation:HumansCells
    125. Brennan AT, Maskew M, Ive P, Shearer K, Long L, Sanne I, Fox MP. Increases in regimen durability associated with the introduction of tenofovir at a large public-sector clinic in Johannesburg, South Africa. J Int AIDS Soc. 2013 Nov 19; 16:18794. PMID: 24256692; PMCID: PMC3835788.
      Citations: 15     Fields:    Translation:Humans
    126. Walensky RP, Ross EL, Kumarasamy N, Wood R, Noubary F, Paltiel AD, Nakamura YM, Godbole SV, Panchia R, Sanne I, Weinstein MC, Losina E, Mayer KH, Chen YQ, Wang L, McCauley M, Gamble T, Seage GR, Cohen MS, Freedberg KA. Cost-effectiveness of HIV treatment as prevention in serodiscordant couples. N Engl J Med. 2013 Oct 31; 369(18):1715-25. PMID: 24171517; PMCID: PMC3913536.
      Citations: 77     Fields:    Translation:HumansPHPublic Health
    127. Menezes CN, Crowther NJ, Duarte R, Van Amsterdam D, Evans D, Dickens C, Dix-Peek T, Rassool M, Prinsloo A, Raal F, Sanne I. A randomized clinical trial comparing metabolic parameters after 48 weeks of standard- and low-dose stavudine therapy and tenofovir disoproxil fumarate therapy in HIV-infected South African patients. HIV Med. 2014 Jan; 15(1):3-12. PMID: 23980620.
      Citations: 8     Fields:    Translation:Humans
    128. Dhana AV, Howell P, Sanne I, Spencer D. Identification of Mycobacterium tuberculosis from pericardial fluid using the new Xpert MTB/RIF assay. BMJ Case Rep. 2013 Aug 28; 2013. PMID: 23986128; PMCID: PMC3762401.
      Citations: 6     Fields:    Translation:Humans
    129. Takuva S, Maskew M, Brennan AT, Sanne I, Macphail AP, Fox MP. Anemia among HIV-Infected Patients Initiating Antiretroviral Therapy in South Africa: Improvement in Hemoglobin regardless of Degree of Immunosuppression and the Initiating ART Regimen. J Trop Med. 2013; 2013:162950. PMID: 24069036; PMCID: PMC3771419.
      Citations: 32     
    130. Shearer K, Fox MP, Maskew M, Berhanu R, Long L, Sanne I. The impact of choice of NNRTI on short-term treatment outcomes among HIV-infected patients prescribed tenofovir and lamivudine in Johannesburg, South Africa. PLoS One. 2013; 8(8):e71719. PMID: 23940782; PMCID: PMC3737125.
      Citations: 8     Fields:    Translation:Humans
    131. Evans D, McNamara L, Maskew M, Selibas K, van Amsterdam D, Baines N, Webster T, Sanne I. Impact of nutritional supplementation on immune response, body mass index and bioelectrical impedance in HIV-positive patients starting antiretroviral therapy. Nutr J. 2013 Aug 06; 12:111. PMID: 23919622; PMCID: PMC3750332.
      Citations: 14     Fields:    Translation:Humans
    132. Fogel JM, Wang L, Parsons TL, Ou SS, Piwowar-Manning E, Chen Y, Mudhune VO, Hosseinipour MC, Kumwenda J, Hakim JG, Chariyalertsak S, Panchia R, Sanne I, Kumarasamy N, Grinsztejn B, Makhema J, Pilotto J, Santos BR, Mayer KH, McCauley M, Gamble T, Bumpus NN, Hendrix CW, Cohen MS, Eshleman SH. Undisclosed antiretroviral drug use in a multinational clinical trial (HIV Prevention Trials Network 052). J Infect Dis. 2013 Nov 15; 208(10):1624-8. PMID: 23908493; PMCID: PMC3805242.
      Citations: 58     Fields:    Translation:HumansCellsCTClinical Trials
    133. Larson BA, Schnippel K, Brennan A, Long L, Xulu T, Maotoe T, Rosen S, Sanne I, Fox MP. Same-Day CD4 Testing to Improve Uptake of HIV Care and Treatment in South Africa: Point-of-Care Is Not Enough. AIDS Res Treat. 2013; 2013:941493. PMID: 23956850; PMCID: PMC3730392.
      Citations: 25     
    134. Schnippel K, Long L, Meyer-Rath G, Sanne I, Rosen S, Stevens W. Impact and costs of algorithms for the diagnosis of adults with pulmonary tuberculosis in South Africa. S Afr Med J. 2013 Jul; 103(7):436. PMID: 23946950.
      Citations: 2     Fields:    Translation:Humans
    135. Hanrahan CF, Selibas K, Deery CB, Dansey H, Clouse K, Bassett J, Scott L, Stevens W, Sanne I, Van Rie A. Time to treatment and patient outcomes among TB suspects screened by a single point-of-care xpert MTB/RIF at a primary care clinic in Johannesburg, South Africa. PLoS One. 2013; 8(6):e65421. PMID: 23762367; PMCID: PMC3675091.
      Citations: 49     Fields:    Translation:HumansCells
    136. Van Rie A, Page-Shipp L, Mellet K, Scott L, Mkhwnazi M, Jong E, Omar T, Beylis N, Stevens W, Sanne I, Menezes CN. Diagnostic accuracy and effectiveness of the Xpert MTB/RIF assay for the diagnosis of HIV-associated lymph node tuberculosis. Eur J Clin Microbiol Infect Dis. 2013 Nov; 32(11):1409-15. PMID: 23660698.
      Citations: 13     Fields:    Translation:Humans
    137. Luetkemeyer AF, Rosenkranz SL, Lu D, Marzan F, Ive P, Hogg E, Swindells S, Benson CA, Grinsztejn B, Sanne IM, Havlir DV, Aweeka F, Adult AIDS Clinical Trials Group A5221 Study Team. Relationship between weight, efavirenz exposure, and virologic suppression in HIV-infected patients on rifampin-based tuberculosis treatment in the AIDS Clinical Trials Group A5221 STRIDE Study. Clin Infect Dis. 2013 Aug; 57(4):586-93. PMID: 23592830; PMCID: PMC3719885.
      Citations: 31     Fields:    Translation:Humans
    138. Zinn RJ, Serrurier C, Takuva S, Sanne I, Menezes CN. HIV-associated lipodystrophy in South Africa: the impact on the patient and the impact on the plastic surgeon. J Plast Reconstr Aesthet Surg. 2013 Jun; 66(6):839-44. PMID: 23545227.
      Citations: 4     Fields:    Translation:Humans
    139. Jong E, Sanne IM, van Rie A, Menezes CN. A hospital-based tuberculosis focal point to improve tuberculosis care provision in a very high burden setting. Public Health Action. 2013 Mar 21; 3(1):51-5. PMID: 26392996; PMCID: PMC4463085.
      Citations: 4     
    140. Westreich D, Maskew M, Evans D, Firnhaber C, Majuba P, Sanne I. Incident pregnancy and time to death or AIDS among HIV-positive women receiving antiretroviral therapy. PLoS One. 2013; 8(3):e58117. PMID: 23520489; PMCID: PMC3592862.
      Citations: 10     Fields:    Translation:HumansCTClinical Trials
    141. Van Rie A, Page-Shipp L, Hanrahan CF, Schnippel K, Dansey H, Bassett J, Clouse K, Scott L, Stevens W, Sanne I. Point-of-care Xpert® MTB/RIF for smear-negative tuberculosis suspects at a primary care clinic in South Africa. Int J Tuberc Lung Dis. 2013 Mar; 17(3):368-72. PMID: 23407225; PMCID: PMC4445423.
      Citations: 25     Fields:    Translation:HumansCells
    142. Clouse K, Pettifor A, Maskew M, Bassett J, Van Rie A, Gay C, Behets F, Sanne I, Fox MP. Initiating antiretroviral therapy when presenting with higher CD4 cell counts results in reduced loss to follow-up in a resource-limited setting. AIDS. 2013 Feb 20; 27(4):645-50. PMID: 23169326; PMCID: PMC3646627.
      Citations: 40     Fields:    Translation:HumansCells
    143. Brennan AT, Maskew M, Sanne I, Fox MP. The interplay between CD4 cell count, viral load suppression and duration of antiretroviral therapy on mortality in a resource-limited setting. Trop Med Int Health. 2013 May; 18(5):619-31. PMID: 23419157; PMCID: PMC3625450.
      Citations: 25     Fields:    Translation:HumansCells
    144. Clouse K, Pettifor A, Shearer K, Maskew M, Bassett J, Larson B, Van Rie A, Sanne I, Fox MP. Loss to follow-up before and after delivery among women testing HIV positive during pregnancy in Johannesburg, South Africa. Trop Med Int Health. 2013 Apr; 18(4):451-60. PMID: 23374278; PMCID: PMC3600093.
      Citations: 73     Fields:    Translation:HumansPHPublic Health
    145. Phillips E, Bartlett JA, Sanne I, Lederman MM, Hinkle J, Rousseau F, Dunn D, Pavlos R, James I, Mallal SA, Haas DW. Associations between HLA-DRB1*0102, HLA-B*5801, and hepatotoxicity during initiation of nevirapine-containing regimens in South Africa. J Acquir Immune Defic Syndr. 2013 Feb 01; 62(2):e55-7. PMID: 23328091; PMCID: PMC3551216.
      Citations: 27     Fields:    Translation:Humans
    146. Clouse K, Pettifor AE, Maskew M, Bassett J, Van Rie A, Behets F, Gay C, Sanne I, Fox MP. Patient retention from HIV diagnosis through one year on antiretroviral therapy at a primary health care clinic in Johannesburg, South Africa. J Acquir Immune Defic Syndr. 2013 Feb 01; 62(2):e39-46. PMID: 23011400; PMCID: PMC3548953.
      Citations: 58     Fields:    Translation:Humans
    147. Voss De Lima Y, Evans D, Page-Shipp L, Barnard A, Sanne I, Menezes CN, Van Rie A. Linkage to care and treatment for TB and HIV among people newly diagnosed with TB or HIV-associated TB at a large, inner city South African hospital. PLoS One. 2013; 8(1):e49140. PMID: 23341869; PMCID: PMC3547004.
      Citations: 16     Fields:    Translation:Humans
    148. Schnippel K, Meyer-Rath G, Long L, Stevens WS, Sanne I, Rosen S. Diagnosing Xpert MTB/RIF negative TB: impact and cost of alternative algorithms for South Africa. S Afr Med J. 2013 Jan 14; 103(2):101-6. PMID: 23374320.
      Citations: 18     Fields:    Translation:HumansCells
    149. Maskew M, Westreich D, Firnhaber C, Sanne I. Tenofovir use and pregnancy among women initiating HAART. AIDS. 2012 Nov 28; 26(18):2393-7. PMID: 22951630; PMCID: PMC3725726.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    150. Schnippel K, Rosen S, Shearer K, Martinson N, Long L, Sanne I, Variava E. Costs of inpatient treatment for multi-drug-resistant tuberculosis in South Africa. Trop Med Int Health. 2013 Jan; 18(1):109-16. PMID: 23170876.
      Citations: 26     Fields:    Translation:Humans
    151. Menezes CN, Duarte R, Dickens C, Dix-Peek T, Van Amsterdam D, John MA, Ive P, Maskew M, Macphail P, Fox MP, Raal F, Sanne I, Crowther NJ. The early effects of stavudine compared with tenofovir on adipocyte gene expression, mitochondrial DNA copy number and metabolic parameters in South African HIV-infected patients: a randomized trial. HIV Med. 2013 Apr; 14(4):217-25. PMID: 23036096.
      Citations: 2     Fields:    Translation:HumansCells
    152. Fox MP, Shearer K, Maskew M, Macleod W, Majuba P, Macphail P, Sanne I. Treatment outcomes after 7 years of public-sector HIV treatment. AIDS. 2012 Sep 10; 26(14):1823-8. PMID: 22739391; PMCID: PMC3600649.
      Citations: 27     Fields:    Translation:Humans
    153. Clouse K, Page-Shipp L, Dansey H, Moatlhodi B, Scott L, Bassett J, Stevens W, Sanne I, Van Rie A. Implementation of Xpert MTB/RIF for routine point-of-care diagnosis of tuberculosis at the primary care level. S Afr Med J. 2012 Sep 07; 102(10):805-7. PMID: 23034211.
      Citations: 36     Fields:    Translation:HumansCells
    154. Page-Shipp L, Voss De Lima Y, Clouse K, de Vos J, Evarts L, Bassett J, Sanne I, Van Rie A. TB/HIV integration at primary care level: A quantitative assessment at 3 clinics in Johannesburg, South Africa. South Afr J HIV Med. 2012 Sep; 13(3):138-143. PMID: 26069466; PMCID: PMC4461002.
      Citations: 5     
    155. El-Sadr WM, Holmes CB, Mugyenyi P, Thirumurthy H, Ellerbrock T, Ferris R, Sanne I, Asiimwe A, Hirnschall G, Nkambule RN, Stabinski L, Affrunti M, Teasdale C, Zulu I, Whiteside A. Scale-up of HIV treatment through PEPFAR: a historic public health achievement. J Acquir Immune Defic Syndr. 2012 Aug 15; 60 Suppl 3:S96-104. PMID: 22797746; PMCID: PMC3445041.
      Citations: 58     Fields:    Translation:HumansPHPublic Health
    156. Takuva S, Westreich D, Menezes CN, McNamara L, Sanne I, Page-Shipp L, Maskew M. Antiretroviral therapy initiation during tuberculosis treatment and HIV-RNA and CD4 T-lymphocyte responses. Int J Tuberc Lung Dis. 2012 Oct; 16(10):1358-64. PMID: 22863288; PMCID: PMC3727657.
      Citations: 1     Fields:    Translation:HumansCells
    157. Azzoni L, Foulkes AS, Firnhaber C, Yin X, Xiang ZQ, Li Y, Stevens W, Gross R, Ertl HC, Sanne I, Montaner LJ. Antiretroviral therapy interruptions result in loss of protective humoral immunity to neoantigens in HIV-infected individuals. AIDS. 2012 Jul 17; 26(11):1355-62. PMID: 22516873; PMCID: PMC3548620.
      Citations: 2     Fields:    Translation:HumansCells
    158. Schnippel K, Meyer-Rath G, Long L, MacLeod W, Sanne I, Stevens WS, Rosen S. Scaling up Xpert MTB/RIF technology: the costs of laboratory- vs. clinic-based roll-out in South Africa. Trop Med Int Health. 2012 Sep; 17(9):1142-51. PMID: 22686606; PMCID: PMC3506730.
      Citations: 34     Fields:    Translation:Humans
    159. Robertson K, Jiang H, Kumwenda J, Supparatpinyo K, Evans S, Campbell TB, Price R, Tripathy S, Kumarasamy N, La Rosa A, Santos B, 5199 study team, Silva MT, Montano S, Kanyama C, Faesen S, Murphy R, Hall C, Marra CM, Marcus C, Berzins B, Allen R, Housseinipour M, Amod F, Sanne I, Hakim J, Walawander A, Nair A, AIDS Clinical Trials Group. Improved neuropsychological and neurological functioning across three antiretroviral regimens in diverse resource-limited settings: AIDS Clinical Trials Group study a5199, the International Neurological Study. Clin Infect Dis. 2012 Sep; 55(6):868-76. PMID: 22661489; PMCID: PMC3491853.
      Citations: 41     Fields:    Translation:HumansCells
    160. Meyer-Rath G, Schnippel K, Long L, MacLeod W, Sanne I, Stevens W, Pillay S, Pillay Y, Rosen S. The impact and cost of scaling up GeneXpert MTB/RIF in South Africa. PLoS One. 2012; 7(5):e36966. PMID: 22693561; PMCID: PMC3365041.
      Citations: 86     Fields:    Translation:HumansCells
    161. Brehm JH, Koontz DL, Wallis CL, Shutt KA, Sanne I, Wood R, McIntyre JA, Stevens WS, Sluis-Cremer N, Mellors JW, CIPRA-SA Project 1 Study Team. Frequent emergence of N348I in HIV-1 subtype C reverse transcriptase with failure of initial therapy reduces susceptibility to reverse-transcriptase inhibitors. Clin Infect Dis. 2012 Sep; 55(5):737-45. PMID: 22618567; PMCID: PMC3491849.
      Citations: 23     Fields:    Translation:HumansCells
    162. Azzoni L, Foulkes AS, Liu Y, Li X, Johnson M, Smith C, Kamarulzaman AB, Montaner J, Mounzer K, Saag M, Cahn P, Cesar C, Krolewiecki A, Sanne I, Montaner LJ. Prioritizing CD4 count monitoring in response to ART in resource-constrained settings: a retrospective application of prediction-based classification. PLoS Med. 2012; 9(4):e1001207. PMID: 22529752; PMCID: PMC3328436.
      Citations: 5     Fields:    Translation:HumansCells
    163. Fox MP, Maskew M, MacPhail AP, Long L, Brennan AT, Westreich D, MacLeod WB, Majuba P, Sanne IM. Cohort profile: the Themba Lethu Clinical Cohort, Johannesburg, South Africa. Int J Epidemiol. 2013 Apr; 42(2):430-9. PMID: 22434860; PMCID: PMC3619949.
      Citations: 63     Fields:    Translation:Humans
    164. Maskew M, Westreich D, Fox MP, Maotoe T, Sanne IM. Effectiveness and safety of 30 mg versus 40 mg stavudine regimens: a cohort study among HIV-infected adults initiating HAART in South Africa. J Int AIDS Soc. 2012 Mar 12; 15(1):13. PMID: 22410312; PMCID: PMC3313885.
      Citations: 9     Fields:    Translation:HumansCells
    165. Kuritzkes DR, Hakim JG, Sanne I. Least among equals. Clin Infect Dis. 2012 Mar; 54(6):876-7. PMID: 22357810; PMCID: PMC3284211.
      Citations:    Fields:    Translation:Humans
    166. Evans D, Maskew M, Sanne I. Increased risk of mortality and loss to follow-up among HIV-positive patients with oropharyngeal candidiasis and malnutrition before antiretroviral therapy initiation: a retrospective analysis from a large urban cohort in Johannesburg, South Africa. Oral Surg Oral Med Oral Pathol Oral Radiol. 2012 Mar; 113(3):362-72. PMID: 22669142; PMCID: PMC3370659.
      Citations: 13     Fields:    Translation:Humans
    167. Wallis CL, Papathanasopolous MA, Fox M, Conradie F, Ive P, Orrell C, Zeinecker J, Sanne I, Wood R, McIntyre J, Stevens W, CIPRA-SA project 1 study team. Low rates of nucleoside reverse transcriptase inhibitor resistance in a well-monitored cohort in South Africa on antiretroviral therapy. Antivir Ther. 2012; 17(2):313-20. PMID: 22293461; PMCID: PMC3600633.
      Citations: 14     Fields:    Translation:HumansCells
    168. Conradie F, Foulkes AS, Ive P, Yin X, Roussos K, Glencross DK, Lawrie D, Stevens W, Montaner LJ, Sanne I, Azzoni L. Natural killer cell activation distinguishes Mycobacterium tuberculosis-mediated immune reconstitution syndrome from chronic HIV and HIV/MTB coinfection. J Acquir Immune Defic Syndr. 2011 Nov 01; 58(3):309-18. PMID: 21826013; PMCID: PMC3196770.
      Citations: 28     Fields:    Translation:HumansCells
    169. Brennan AT, Long L, Maskew M, Sanne I, Jaffray I, MacPhail P, Fox MP. Outcomes of stable HIV-positive patients down-referred from a doctor-managed antiretroviral therapy clinic to a nurse-managed primary health clinic for monitoring and treatment. AIDS. 2011 Oct 23; 25(16):2027-36. PMID: 21997488; PMCID: PMC3669640.
      Citations: 44     Fields:    Translation:HumansCells
    170. Havlir DV, Kendall MA, Ive P, Kumwenda J, Swindells S, Qasba SS, Luetkemeyer AF, Hogg E, Rooney JF, Wu X, Hosseinipour MC, Lalloo U, Veloso VG, Some FF, Kumarasamy N, Padayatchi N, Santos BR, Reid S, Hakim J, Mohapi L, Mugyenyi P, Sanchez J, Lama JR, Pape JW, Sanchez A, Asmelash A, Moko E, Sawe F, Andersen J, Sanne I, AIDS Clinical Trials Group Study A5221. Timing of antiretroviral therapy for HIV-1 infection and tuberculosis. N Engl J Med. 2011 Oct 20; 365(16):1482-91. PMID: 22010914; PMCID: PMC3327101.
      Citations: 272     Fields:    Translation:HumansCells
    171. Maskew M, Brennan AT, MacPhail AP, Sanne IM, Fox MP. Poorer ART outcomes with increasing age at a large public sector HIV clinic in Johannesburg, South Africa. J Int Assoc Physicians AIDS Care (Chic). 2012 Jan-Feb; 11(1):57-65. PMID: 21951728; PMCID: PMC3272319.
      Citations: 30     Fields:    Translation:Humans
    172. Menezes CN, Maskew M, Sanne I, Crowther NJ, Raal FJ. A longitudinal study of stavudine-associated toxicities in a large cohort of South African HIV infected subjects. BMC Infect Dis. 2011 Sep 17; 11:244. PMID: 21923929; PMCID: PMC3189398.
      Citations: 30     Fields:    Translation:Humans
    173. Brennan A, Evans D, Maskew M, Naicker S, Ive P, Sanne I, Maotoe T, Fox M. Relationship between renal dysfunction, nephrotoxicity and death among HIV adults on tenofovir. AIDS. 2011 Aug 24; 25(13):1603-9. PMID: 21646902; PMCID: PMC3586413.
      Citations: 49     Fields:    Translation:Humans
    174. Westreich D, Cole SR, Nagar S, Maskew M, van der Horst C, Sanne I. Pregnancy and virologic response to antiretroviral therapy in South Africa. PLoS One. 2011; 6(8):e22778. PMID: 21829650; PMCID: PMC3149058.
      Citations: 18     Fields:    Translation:Humans
    175. Azzoni L, Foulkes AS, Firnhaber C, Yin X, Crowther NJ, Glencross D, Lawrie D, Stevens W, Papasavvas E, Sanne I, Montaner LJ. Metabolic and anthropometric parameters contribute to ART-mediated CD4+ T cell recovery in HIV-1-infected individuals: an observational study. J Int AIDS Soc. 2011 Jul 29; 14:37. PMID: 21801351; PMCID: PMC3163506.
      Citations: 6     Fields:    Translation:HumansCells
    176. Scott LE, McCarthy K, Gous N, Nduna M, Van Rie A, Sanne I, Venter WF, Duse A, Stevens W. Comparison of Xpert MTB/RIF with other nucleic acid technologies for diagnosing pulmonary tuberculosis in a high HIV prevalence setting: a prospective study. PLoS Med. 2011 Jul; 8(7):e1001061. PMID: 21814495; PMCID: PMC3144192.
      Citations: 79     Fields:    Translation:HumansCells
    177. Robertson K, Kumwenda J, Supparatpinyo K, Jiang JH, Evans S, Campbell TB, Price RW, Murphy R, Hall C, Marra CM, Marcus C, Berzins B, Masih R, Santos B, Silva MT, Kumarasamy N, Walawander A, Nair A, Tripathy S, Kanyama C, Hosseinipour M, Montano S, La Rosa A, Amod F, Sanne I, Firnhaber C, Hakim J, Brouwers P, AIDS Clinical Trials Group. A multinational study of neurological performance in antiretroviral therapy-naïve HIV-1-infected persons in diverse resource-constrained settings. J Neurovirol. 2011 Oct; 17(5):438-47. PMID: 21786076; PMCID: PMC3362044.
      Citations: 27     Fields:    Translation:HumansCells
    178. Long L, Brennan A, Fox MP, Ndibongo B, Jaffray I, Sanne I, Rosen S. Treatment outcomes and cost-effectiveness of shifting management of stable ART patients to nurses in South Africa: an observational cohort. PLoS Med. 2011 Jul; 8(7):e1001055. PMID: 21811402; PMCID: PMC3139666.
      Citations: 71     Fields:    Translation:Humans
    179. Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, Hakim JG, Kumwenda J, Grinsztejn B, Pilotto JH, Godbole SV, Mehendale S, Chariyalertsak S, Santos BR, Mayer KH, Hoffman IF, Eshleman SH, Piwowar-Manning E, Wang L, Makhema J, Mills LA, de Bruyn G, Sanne I, Eron J, Gallant J, Havlir D, Swindells S, Ribaudo H, Elharrar V, Burns D, Taha TE, Nielsen-Saines K, Celentano D, Essex M, Fleming TR, HPTN 052 Study Team. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011 Aug 11; 365(6):493-505. PMID: 21767103; PMCID: PMC3200068.
      Citations: 3469     Fields:    Translation:HumansCellsPHPublic Health
    180. Firnhaber C, Azzoni L, Foulkes AS, Gross R, Yin X, Van Amsterdam D, Schulze D, Glencross DK, Stevens W, Hunt G, Morris L, Fox L, Sanne I, Montaner LJ. Randomized trial of time-limited interruptions of protease inhibitor-based antiretroviral therapy (ART) vs. continuous therapy for HIV-1 infection. PLoS One. 2011; 6(6):e21450. PMID: 21738668; PMCID: PMC3125169.
      Citations: 3     Fields:    Translation:Cells
    181. Rosen S, Long L, Sanne I, Stevens WS, Fox MP. The net cost of incorporating resistance testing into HIV/AIDS treatment in South Africa: a Markov model with primary data. J Int AIDS Soc. 2011 May 15; 14:24. PMID: 21575155; PMCID: PMC3119176.
      Citations: 16     Fields:    Translation:HumansCells
    182. Van Rie A, Westreich D, Sanne I. Tuberculosis in patients receiving antiretroviral treatment: incidence, risk factors, and prevention strategies. J Acquir Immune Defic Syndr. 2011 Apr; 56(4):349-55. PMID: 20926954; PMCID: PMC3319435.
      Citations: 61     Fields:    Translation:Humans
    183. Orrell C, Cohen K, Conradie F, Zeinecker J, Ive P, Sanne I, Wood R. Efavirenz and rifampicin in the South African context: is there a need to dose-increase efavirenz with concurrent rifampicin therapy? Antivir Ther. 2011; 16(4):527-34. PMID: 21685540; PMCID: PMC3145153.
      Citations: 11     Fields:    Translation:HumansCTClinical Trials
    184. Madhi SA, Maskew M, Koen A, Kuwanda L, Besselaar TG, Naidoo D, Cohen C, Valette M, Cutland CL, Sanne I. Trivalent inactivated influenza vaccine in African adults infected with human immunodeficient virus: double blind, randomized clinical trial of efficacy, immunogenicity, and safety. Clin Infect Dis. 2011 Jan 01; 52(1):128-37. PMID: 21148531.
      Citations: 36     Fields:    Translation:HumansCells
    185. Brennan AT, Maskew M, Sanne I, Fox MP. The importance of clinic attendance in the first six months on antiretroviral treatment: a retrospective analysis at a large public sector HIV clinic in South Africa. J Int AIDS Soc. 2010 Dec 07; 13:49. PMID: 21134297; PMCID: PMC3012655.
      Citations: 49     Fields:    Translation:Humans
    186. Wallis CL, Mellors JW, Venter WD, Sanne I, Stevens W. Protease Inhibitor Resistance Is Uncommon in HIV-1 Subtype C Infected Patients on Failing Second-Line Lopinavir/r-Containing Antiretroviral Therapy in South Africa. AIDS Res Treat. 2011; 2011:769627. PMID: 21490784; PMCID: PMC3066558.
      Citations: 48     
    187. Van Rie A, Page-Shipp L, Scott L, Sanne I, Stevens W. Xpert(®) MTB/RIF for point-of-care diagnosis of TB in high-HIV burden, resource-limited countries: hype or hope? Expert Rev Mol Diagn. 2010 Oct; 10(7):937-46. PMID: 20964612.
      Citations: 63     Fields:    Translation:HumansCells
    188. Rosen S, Larson B, Brennan A, Long L, Fox M, Mongwenyana C, Ketlhapile M, Sanne I. Economic outcomes of patients receiving antiretroviral therapy for HIV/AIDS in South Africa are sustained through three years on treatment. PLoS One. 2010 Sep 14; 5(9):e12731. PMID: 20856821; PMCID: PMC2939080.
      Citations: 23     Fields:    Translation:Humans
    189. Azzoni L, Crowther NJ, Firnhaber C, Foulkes AS, Yin X, Glencross D, Gross R, Kaplan MD, Papasavvas E, Schulze D, Stevens W, van der Merwe T, Waisberg R, Sanne I, Montaner LJ. Association between HIV replication and serum leptin levels: an observational study of a cohort of HIV-1-infected South African women. J Int AIDS Soc. 2010 Sep 07; 13:33. PMID: 20822522; PMCID: PMC2941743.
      Citations: 9     Fields:    Translation:HumansCells
    190. Boulle A, Clayden P, Cohen K, Cohen T, Conradie F, Dong K, Geffen N, Grimwood A, Hurtado R, Kenyon C, Lawn S, Maartens G, Meintjes G, Mendelson M, Murray M, Rangaka M, Sanne I, Spencer D, Taljaard J, Variava E, Venter WD, Wilson D. Prolonged deferral of antiretroviral therapy in the SAPIT trial: did we need a clinical trial to tell us that this would increase mortality? S Afr Med J. 2010 Sep 07; 100(9):566, 568, 570-1. PMID: 20822639.
      Citations: 5     Fields:    Translation:Humans
    191. Fox MP, Sanne IM, Conradie F, Zeinecker J, Orrell C, Ive P, Rassool M, Dehlinger M, van der Horst C, McIntyre J, Wood R. Initiating patients on antiretroviral therapy at CD4 cell counts above 200 cells/microl is associated with improved treatment outcomes in South Africa. AIDS. 2010 Aug 24; 24(13):2041-50. PMID: 20613459; PMCID: PMC2914833.
      Citations: 23     Fields:    Translation:Humans
    192. Sanne I, Orrell C, Fox MP, Conradie F, Ive P, Zeinecker J, Cornell M, Heiberg C, Ingram C, Panchia R, Rassool M, Gonin R, Stevens W, Truter H, Dehlinger M, van der Horst C, McIntyre J, Wood R, CIPRA-SA Study Team. Nurse versus doctor management of HIV-infected patients receiving antiretroviral therapy (CIPRA-SA): a randomised non-inferiority trial. Lancet. 2010 Jul 03; 376(9734):33-40. PMID: 20557927; PMCID: PMC3145152.
      Citations: 112     Fields:    Translation:HumansCells
    193. Grant PM, Komarow L, Andersen J, Sereti I, Pahwa S, Lederman MM, Eron J, Sanne I, Powderly W, Hogg E, Suckow C, Zolopa A. Risk factor analyses for immune reconstitution inflammatory syndrome in a randomized study of early vs. deferred ART during an opportunistic infection. PLoS One. 2010 Jul 01; 5(7):e11416. PMID: 20617176; PMCID: PMC2895658.
      Citations: 68     Fields:    Translation:HumansCells
    194. Larson BA, Brennan A, McNamara L, Long L, Rosen S, Sanne I, Fox MP. Early loss to follow up after enrolment in pre-ART care at a large public clinic in Johannesburg, South Africa. Trop Med Int Health. 2010 Jun; 15 Suppl 1:43-7. PMID: 20586959; PMCID: PMC2954490.
      Citations: 69     Fields:    Translation:Humans
    195. Marais BJ, Raviglione MC, Donald PR, Harries AD, Kritski AL, Graham SM, El-Sadr WM, Harrington M, Churchyard G, Mwaba P, Sanne I, Kaufmann SH, Whitty CJ, Atun R, Zumla A. Scale-up of services and research priorities for diagnosis, management, and control of tuberculosis: a call to action. Lancet. 2010 Jun 19; 375(9732):2179-91. PMID: 20488521.
      Citations: 50     Fields:    Translation:Humans
    196. Larson BA, Brennan A, McNamara L, Long L, Rosen S, Sanne I, Fox MP. Lost opportunities to complete CD4+ lymphocyte testing among patients who tested positive for HIV in South Africa. Bull World Health Organ. 2010 Sep 01; 88(9):675-80. PMID: 20865072; PMCID: PMC2930360.
      Citations: 42     Fields:    Translation:HumansCells
    197. Wallis CL, Mellors JW, Venter WD, Sanne I, Stevens W. Varied patterns of HIV-1 drug resistance on failing first-line antiretroviral therapy in South Africa. J Acquir Immune Defic Syndr. 2010 Apr 01; 53(4):480-4. PMID: 19801944.
      Citations: 58     Fields:    Translation:HumansCells
    198. Fox MP, Ive P, Long L, Maskew M, Sanne I. High rates of survival, immune reconstitution, and virologic suppression on second-line antiretroviral therapy in South Africa. J Acquir Immune Defic Syndr. 2010 Apr 01; 53(4):500-6. PMID: 19838128.
      Citations: 53     Fields:    Translation:Humans
    199. Flexner C, Tierney C, Gross R, Andrade A, Lalama C, Eshleman SH, Aberg J, Sanne I, Parsons T, Kashuba A, Rosenkranz SL, Kmack A, Ferguson E, Dehlinger M, Mildvan D, ACTG A5073 Study Team. Comparison of once-daily versus twice-daily combination antiretroviral therapy in treatment-naive patients: results of AIDS clinical trials group (ACTG) A5073, a 48-week randomized controlled trial. Clin Infect Dis. 2010 Apr 01; 50(7):1041-52. PMID: 20192725; PMCID: PMC2833234.
      Citations: 18     Fields:    Translation:HumansCells
    200. Long L, Fox M, Sanne I, Rosen S. The high cost of second-line antiretroviral therapy for HIV/AIDS in South Africa. AIDS. 2010 Mar 27; 24(6):915-9. PMID: 20042849.
      Citations: 55     Fields:    Translation:HumansCells
    201. Fox MP, Brennan A, Maskew M, MacPhail P, Sanne I. Using vital registration data to update mortality among patients lost to follow-up from ART programmes: evidence from the Themba Lethu Clinic, South Africa. Trop Med Int Health. 2010 Apr; 15(4):405-13. PMID: 20180931; PMCID: PMC2951133.
      Citations: 84     Fields:    Translation:Humans
    202. Sanne IM, Westreich D, Macphail AP, Rubel D, Majuba P, Van Rie A. Long term outcomes of antiretroviral therapy in a large HIV/AIDS care clinic in urban South Africa: a prospective cohort study. J Int AIDS Soc. 2009 Dec 17; 12:38. PMID: 20017918; PMCID: PMC2811100.
      Citations: 49     Fields:    
    203. Stevens WS, Wallis CL, Sanne I, Venter F. Will etravirine work in patients failing nonnucleoside reverse transcriptase inhibitor-based treatment in southern Africa? J Acquir Immune Defic Syndr. 2009 Dec; 52(5):655-6. PMID: 19935208.
      Citations: 7     Fields:    Translation:HumansCells
    204. Firnhaber C, Van Le H, Pettifor A, Schulze D, Michelow P, Sanne IM, Lewis DA, Williamson AL, Allan B, Williams S, Rinas A, Levin S, Smith JS. Association between cervical dysplasia and human papillomavirus in HIV seropositive women from Johannesburg South Africa. Cancer Causes Control. 2010 Mar; 21(3):433-43. PMID: 19949850; PMCID: PMC2835728.
      Citations: 47     Fields:    Translation:HumansCells
    205. du Plessis CD, Aden AA, Firnhaber C, Sanne I. Complex regional pain syndrome in a HIV seropositive patient starting antiretroviral therapy. J Clin Rheumatol. 2009 Oct; 15(7):371-2. PMID: 20009979.
      Citations: 1     Fields:    Translation:Humans
    206. Westreich DJ, Sanne I, Maskew M, Malope-Kgokong B, Conradie F, Majuba P, Funk MJ, Kaufman JS, Van Rie A, Macphail P. Tuberculosis treatment and risk of stavudine substitution in first-line antiretroviral therapy. Clin Infect Dis. 2009 Jun 01; 48(11):1617-23. PMID: 19385733; PMCID: PMC2787193.
      Citations: 20     Fields:    Translation:Humans
    207. Zolopa A, Andersen J, Powderly W, Sanchez A, Sanne I, Suckow C, Hogg E, Komarow L. Early antiretroviral therapy reduces AIDS progression/death in individuals with acute opportunistic infections: a multicenter randomized strategy trial. PLoS One. 2009; 4(5):e5575. PMID: 19440326; PMCID: PMC2680972.
      Citations: 207     Fields:    Translation:Humans
    208. Ferguson YO, Eng E, Bentley M, Sandelowski M, Steckler A, Randall-David E, Piwoz EG, Zulu C, Chasela C, Soko A, Tembo M, Martinson F, Tohill BC, Ahmed Y, Kazembe P, Jamieson DJ, van der Horst C, UNC Project BAN Study Team, Adair L, Ahmed Y, Ait-Khaled M, Albrecht S, Bangdiwala S, Bayer R, Bentley M, Bramson B, Bobrow E, Boyle N, Butera S, Chasela C, Chavula C, Chimerang'ambe J, Chigwenembe M, Chikasema M, Chikhungu N, Chilongozi D, Chiudzu G, Chome L, Cole A, Corbett A, Corneli A, Duerr A, Eliya H, Ellington S, Eron J, Farr S, Ferguson YO, Fiscus S, Galvin S, Guay L, Heilig C, Hoffman I, Hooten E, Hosseinipour M, Hudgens M, Hurst S, Hyde L, Jamieson D, Joaki G, Jones D, Kacheche Z, Kamanga E, Kamanga G, Kampani C, Kamthunzi P, Kamwendo D, Kanyama C, Kashuba A, Kathyola D, Kayira D, Kazembe P, Knight R, Kourtis A, Krysiak R, Kumwenda J, Loeliger E, Luhanga M, Madhlopa V, Majawa M, Maida A, Marcus C, Martinson F, Thoofer N, Matika C, Mayers D, Mayuni I, McDonough M, Meme J, Merry C, Mita K, Mkomawanthu C, Mndala G, Mndala I, Moses A, Msika A, Msungama W, Mtimuni B, Muita J, Mumba N, Musis B, Mwansambo C, Mwapasa G, Nkhoma J, Pendame R, Piwoz E, Raines B, Ramdas Z, Rublein J, Ryan M, Sanne I, Sellers C, Shugars D, Sichali D, Snowden W, Soko A, Spensley A, Steens JM, Tegha G, Tembo M, Thomas R, Tien HC, Tohill B, van der Horst C, Waalberg E, Wiener J, Wilfert C, Wiyo P, Zgambo O, Zimba C. Evaluating nurses' implementation of an infant-feeding counseling protocol for HIV-infected mothers: The Ban Study in Lilongwe, Malawi. AIDS Educ Prev. 2009 Apr; 21(2):141-55. PMID: 19397436; PMCID: PMC2903193.
      Citations: 14     Fields:    Translation:HumansPHPublic Health
    209. Westreich D, MacPhail P, Van Rie A, Malope-Kgokong B, Ive P, Rubel D, Boulmé R, Eron J, Sanne I. Effect of pulmonary tuberculosis on mortality in patients receiving HAART. AIDS. 2009 Mar 27; 23(6):707-15. PMID: 19279444; PMCID: PMC2848384.
      Citations: 28     Fields:    Translation:Humans
    210. Firnhaber C, Zungu K, Levin S, Michelow P, Montaner LJ, McPhail P, Williamson AL, Allan BR, Van der Horst C, Rinas A, Sanne I. Diverse and high prevalence of human papillomavirus associated with a significant high rate of cervical dysplasia in human immunodeficiency virus-infected women in Johannesburg, South Africa. Acta Cytol. 2009 Jan-Feb; 53(1):10-7. PMID: 19248549; PMCID: PMC2922752.
      Citations: 37     Fields:    Translation:HumansCells
    211. Firnhaber C, Viana R, Reyneke A, Schultze D, Malope B, Maskew M, Di Bisceglie A, MacPhail P, Sanne I, Kew M. Occult hepatitis B virus infection in patients with isolated core antibody and HIV co-infection in an urban clinic in Johannesburg, South Africa. Int J Infect Dis. 2009 Jul; 13(4):488-92. PMID: 19081280; PMCID: PMC3016468.
      Citations: 32     Fields:    Translation:Humans
    212. Havlir DV, Getahun H, Sanne I, Nunn P. Opportunities and challenges for HIV care in overlapping HIV and TB epidemics. JAMA. 2008 Jul 23; 300(4):423-30. PMID: 18647985.
      Citations: 57     Fields:    Translation:HumansPHPublic Health
    213. Rosen S, Ketlhapile M, Sanne I, DeSilva MB. Characteristics of patients accessing care and treatment for HIV/AIDS at public and nongovernmental sites in South Africa. J Int Assoc Physicians AIDS Care (Chic). 2008 Jul-Aug; 7(4):200-7. PMID: 18626120.
      Citations: 12     Fields:    Translation:HumansCells
    214. Rosen S, Long L, Sanne I. The outcomes and outpatient costs of different models of antiretroviral treatment delivery in South Africa. Trop Med Int Health. 2008 Aug; 13(8):1005-15. PMID: 18631314.
      Citations: 50     Fields:    Translation:Humans
    215. Rosen S, Long L, Fox M, Sanne I. Cost and cost-effectiveness of switching from stavudine to tenofovir in first-line antiretroviral regimens in South Africa. J Acquir Immune Defic Syndr. 2008 Jul 01; 48(3):334-44. PMID: 18545151.
      Citations: 25     Fields:    Translation:Humans
    216. Rosen S, Ketlhapile M, Sanne I, Desilva MB. Differences in normal activities, job performance and symptom prevalence between patients not yet on antiretroviral therapy and patients initiating therapy in South Africa. AIDS. 2008 Jul; 22 Suppl 1:S131-9. PMID: 18664945.
      Citations: 21     Fields:    Translation:Humans
    217. Firnhaber C, Reyneke A, Schulze D, Malope B, Maskew M, MacPhail P, Sanne I, Di Bisceglie A. The prevalence of hepatitis B co-infection in a South African urban government HIV clinic. S Afr Med J. 2008 Jul; 98(7):541-4. PMID: 18785395; PMCID: PMC3008405.
      Citations: 34     Fields:    Translation:Humans
    218. Glencross DK, Janossy G, Coetzee LM, Lawrie D, Aggett HM, Scott LE, Sanne I, McIntyre JA, Stevens W. Large-scale affordable PanLeucogated CD4+ testing with proactive internal and external quality assessment: in support of the South African national comprehensive care, treatment and management programme for HIV and AIDS. Cytometry B Clin Cytom. 2008; 74 Suppl 1:S40-51. PMID: 18228554.
      Citations: 32     Fields:    Translation:HumansCells
    219. Glencross DK, Janossy G, Coetzee LM, Lawrie D, Scott LE, Sanne I, McIntyre JA, Stevens W. CD8/CD38 activation yields important clinical information of effective antiretroviral therapy: findings from the first year of the CIPRA-SA cohort. Cytometry B Clin Cytom. 2008; 74 Suppl 1:S131-40. PMID: 18228566.
      Citations: 13     Fields:    Translation:HumansCells
    220. Vijayaraghavan A, Efrusy MB, Mazonson PD, Ebrahim O, Sanne IM, Santas CC. Cost-effectiveness of alternative strategies for initiating and monitoring highly active antiretroviral therapy in the developing world. J Acquir Immune Defic Syndr. 2007 Sep 01; 46(1):91-100. PMID: 17621241.
      Citations: 27     Fields:    Translation:Humans
    221. Rosen S, Ketlhapile M, Sanne I, DeSilva MB. Cost to patients of obtaining treatment for HIV/AIDS in South Africa. S Afr Med J. 2007 Jul; 97(7):524-9. PMID: 17805455.
      Citations: 34     Fields:    Translation:Humans
    222. John MA, Menezes CN, Chita G, Sanne I, Grobusch MP. High tuberculosis and HIV coinfection rate, Johannesburg. Emerg Infect Dis. 2007 May; 13(5):795-6. PMID: 18044049; PMCID: PMC2738447.
      Citations: 9     Fields:    Translation:Humans
    223. Haas DW, Bartlett JA, Andersen JW, Sanne I, Wilkinson GR, Hinkle J, Rousseau F, Ingram CD, Shaw A, Lederman MM, Kim RB, Adult AIDS Clinical Trials Group. Pharmacogenetics of nevirapine-associated hepatotoxicity: an Adult AIDS Clinical Trials Group collaboration. Clin Infect Dis. 2006 Sep 15; 43(6):783-6. PMID: 16912957.
      Citations: 44     Fields:    Translation:HumansCells
    224. Gathe JC, Wood R, Sanne I, DeJesus E, Schürmann D, Gladysz A, Garris C, Givens N, Elston R, Yeo J. Long-term (120-Week) antiviral efficacy and tolerability of fosamprenavir/ritonavir once daily in therapy-naive patients with HIV-1 infection: an uncontrolled, open-label, single-arm follow-on study. Clin Ther. 2006 May; 28(5):745-54. PMID: 16861096.
      Citations: 2     Fields:    Translation:HumansCellsCTClinical Trials
    225. Vazquez JA, Skiest DJ, Nieto L, Northland R, Sanne I, Gogate J, Greaves W, Isaacs R. A multicenter randomized trial evaluating posaconazole versus fluconazole for the treatment of oropharyngeal candidiasis in subjects with HIV/AIDS. Clin Infect Dis. 2006 Apr 15; 42(8):1179-86. PMID: 16575739.
      Citations: 40     Fields:    Translation:HumansAnimals
    226. Rosen S, Sanne I, Collier A, Simon JL. Rationing antiretroviral therapy for HIV/AIDS in Africa: choices and consequences. PLoS Med. 2005 Nov; 2(11):e303. PMID: 16159308; PMCID: PMC1215468.
      Citations: 14     Fields:    Translation:Humans
    227. Sanne I, Mommeja-Marin H, Hinkle J, Bartlett JA, Lederman MM, Maartens G, Wakeford C, Shaw A, Quinn J, Gish RG, Rousseau F. Severe hepatotoxicity associated with nevirapine use in HIV-infected subjects. J Infect Dis. 2005 Mar 15; 191(6):825-9. PMID: 15717255.
      Citations: 74     Fields:    Translation:HumansCellsCTClinical Trials
    228. Robertson K, Kopnisky K, Mielke J, Appiah K, Hall C, Price R, Kumwenda J, Kanyama C, Amod F, Marra C, Taylor T, Lalloo U, Jelsma J, Holding P, Boivin M, Birbeck G, Nakasujja N, Sanne I, Parsons TD, Parente A, Tucker K, Assessment of NeuroAIDS in Africa Conference Participants. Assessment of neuroAIDS in Africa. J Neurovirol. 2005; 11 Suppl 1:7-16. PMID: 15960235.
      Citations: 6     Fields:    Translation:Humans
    229. Rosen S, Sanne I, Collier A, Simon JL. Hard choices: rationing antiretroviral therapy for HIV/AIDS in Africa. Lancet. 2005 Jan 22-28; 365(9456):354-6. PMID: 15664233.
      Citations: 11     Fields:    Translation:Humans
    230. Sanne I, van der Horst C. Research as a path to wide-scale implementation of antiretroviral therapy in Africa. J HIV Ther. 2004 Sep; 9(3):65-8. PMID: 15534564.
      Citations:    Fields:    Translation:HumansCells
    231. King MS, Bernstein BM, Walmsley SL, Sherer R, Feinberg J, Sanne I, Cernohous P, Montaner JS, Brun SC, Sun E. Baseline HIV-1 RNA level and CD4 cell count predict time to loss of virologic response to nelfinavir, but not lopinavir/ritonavir, in antiretroviral therapy-naive patients. J Infect Dis. 2004 Jul 15; 190(2):280-4. PMID: 15216462.
      Citations: 6     Fields:    Translation:HumansCellsCTClinical Trials
    232. Conradie F, Sanne I, Venter W, Eron J. Failure of lopinavir-ritonavir (Kaletra)-containing regimen in an antiretroviral-naive patient. AIDS. 2004 Apr 30; 18(7):1084-5. PMID: 15096819.
      Citations: 3     Fields:    Translation:Humans
    233. Murphy RL, Sanne I, Cahn P, Phanuphak P, Percival L, Kelleher T, Giordano M. Dose-ranging, randomized, clinical trial of atazanavir with lamivudine and stavudine in antiretroviral-naive subjects: 48-week results. AIDS. 2003 Dec 05; 17(18):2603-14. PMID: 14685054.
      Citations: 32     Fields:    Translation:HumansCellsCTClinical Trials
    234. Rousseau FS, Wakeford C, Mommeja-Marin H, Sanne I, Moxham C, Harris J, Hulett L, Wang LH, Quinn JB, Barry DW, FTC-102 Clinical Trial Group. Prospective randomized trial of emtricitabine versus lamivudine short-term monotherapy in human immunodeficiency virus-infected patients. J Infect Dis. 2003 Dec 01; 188(11):1652-8. PMID: 14639535.
      Citations: 17     Fields:    Translation:HumansCTClinical Trials
    235. Venter WD, Sanne IM. The cardiovascular consequences of HIV and antiretroviral therapy. Cardiovasc J S Afr. 2003 Sep-Oct; 14(5):225-9. PMID: 14610609.
      Citations: 2     Fields:    Translation:Humans
    236. Diaz M, Douek DC, Valdez H, Hill BJ, Peterson D, Sanne I, Piliero PJ, Koup RA, Green SB, Schnittman S, Lederman MM. T cells containing T cell receptor excision circles are inversely related to HIV replication and are selectively and rapidly released into circulation with antiretroviral treatment. AIDS. 2003 May 23; 17(8):1145-9. PMID: 12819515.
      Citations: 15     Fields:    Translation:HumansCells
    237. Sanne I, Piliero P, Squires K, Thiry A, Schnittman S, AI424-007 Clinical Trial Group. Results of a phase 2 clinical trial at 48 weeks (AI424-007): a dose-ranging, safety, and efficacy comparative trial of atazanavir at three doses in combination with didanosine and stavudine in antiretroviral-naive subjects. J Acquir Immune Defic Syndr. 2003 Jan 01; 32(1):18-29. PMID: 12514410.
      Citations: 51     Fields:    Translation:HumansCellsCTClinical Trials
    238. Hosseinipour MC, Kazembe PN, Sanne IM, van der Horst CM. Challenges in delivering antiretroviral treatment in resource poor countries. AIDS. 2002; 16 Suppl 4:S177-87. PMID: 12699015.
      Citations: 9     Fields:    Translation:Humans
    239. Maartens G, Bekker LG, Sanne I. Deciding when to institute terminal palliative care for AIDS patients--an evidence-based approach. S Afr Med J. 2001 Jul; 91(7):559-60. PMID: 11544966.
      Citations:    Fields:    Translation:HumansCells
    240. Sanne I, Smego RA, Mendelow BV. Systematic review of combination antiretroviral therapy with didanosine plus hydroxyurea: a partial solution to Africa's HIV/AIDS problem? Int J Infect Dis. 2001; 5(1):43-8. PMID: 11285159.
      Citations: 2     Fields:    Translation:Humans
    241. Vaizey CJ, Sanne I, Gilbert JM. Periappendiceal hydatidosis: an unusual cause of right iliac fossa pain. Br J Surg. 1994 Sep; 81(9):1371-2. PMID: 7953419.
      Citations:    Fields:    Translation:HumansAnimals
    Sanne's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (575)
    Explore
    _
    Co-Authors (53)
    Explore
    _
    Similar People (60)
    Explore
    _